https://rjrindex.com/articles/diagnostic-and-prognostic-performance-of-urinary-metabolomic-biomarkers-in-lung-cancer-a-systematic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-imaging-cytology-profiling-system-for-rapid-point-of-care-molecular-diagnosis-of-leptomen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/malignant-leydig-cell-tumor-a-population-level-demographic-study-using-the-national-cancer-database 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-aryl-hydrocarbon-receptor-ahr-modulation-on-survival-in-pre-clinical-head-and-neck-model 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-phase-i-study-of-hsk41959-an-mta-cooperative-prmt5-inhibitor-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-global-phase-12a-trial-of-shr-a1904-a-cldn182-targeting-adc-in-advanced-solid-tumors-expressin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-first-line-comprehensive-genomic-profiling-on-survival-outcomes-for-patients-with-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/towards-hyper-sensitive-mrd-assessment-of-enspyre-as-a-cost-effective-ctdna-detection-technique-usi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-neutrophil-to-lymphocyte-ratio-on-pathological-response-in-her2-positive-breast-cancer-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/statin-exposure-and-clinical-outcomes-in-metastatic-prostate-cancer-a-propensity-matched-trinetx-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-pre-existing-autoimmune-disease-on-outcomes-of-immune-checkpoint-inhibitors-in-non-small-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preclinical-data-of-ibi3028-the-first-clinical-stage-bispecific-dual-payload-adc-targeting-egfrc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcome-of-apalutamide-therapy-in-mhspc-patients-depending-on-age-dose-reduction-and-ps 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preclinical-evaluation-of-ct03-a-cardiosafe-first-in-class-bifunctional-mcl1-degrader-for-the-trea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rituximab-pre-conditioning-in-a-phase-i-study-of-carv3-team-e-for-recurrent-glioblastoma-gbm-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cumulative-incidence-and-risk-factors-of-trastuzumab-deruxtecan-related-interstitial-lung-disease-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identification-and-frequency-of-iegfri-mutations-among 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-multi-omics-to-routine-precision-oncology-biologically-informed-knowledge-transfer-for-pre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-of-cns-lymphoma-patients-treated-with-glucarpidase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-significance-of-iegfri-amplification-in-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-assessment-of-treatment-adherence-among-vorasidenib-treated-patients-with-idh-mutant-glio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/initial-safety-and-efficacy-of-a2b694-a-logic-gated-mesothelin-msln-targeted-tmod-chimeric-antige 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-cell-spatial-analysis-of-the-tumor-immune-microenvironment-in-nsclc-primary-tumors-and-brain 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concomitant-radiotherapy-tremelimumab-and-durvalumab-for-advanced-nsclc-patients-progressing-on-fi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-survival-with-clinical-characteristics-and-cd68cd206-expression-in-stage-iiia-squamo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-landscape-and-evolutionary-dynamics-of-irasi-al 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-immune-checkpoint-inhibitors-with-increased-pancreatitis-risk-in-gastrointestinal-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-of-localized-pulmonary-pleomorphic-adenocarcinoma-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-propensity-score-matched-analysis-comparing-first-line-regional-systemic-and-intralesional-treat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-body-composition-on-cardiac-function-in-women-with-early-breast-cancer-taking-cardioto 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-among-medicare-beneficiaries-treated-with-first-line-1l-bruton-tyrosine-kinase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncoseek-20-an-updated-blood-based-assay-for-multi-cancer-early-detection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-site-central-baseline-imaging-discordance-in-oncology-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/vididencel-an-active-immunotherapy-in-high-grade-serous-ovarian-carcinoma-patients-analysis-of-tum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/platinum-rechallenge-versus-non-platinum-regimens-as-second-line-treatment-for-advanced-thymoma-ana 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outpatient-administration-of-cycle-1-of-bispecific-antibody-therapy-in-hematologic-malignancies-a-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-chemotherapy-plus-disitamab-vedotin-rc48-and-toripalimab-in-her2-overexpressed-local 2026-08-24 monthly 0.7 https://rjrindex.com/articles/echo-cancer-advisor-a-modular-ai-framework-for-interpretable-patient-specific-oncology-decision-su 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-tislelizumab-plus-chemoradiotherapy-for-patients-with-advanced-biliary-tract-cancer-a-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/actionable-germline-findings-in-endometrial-cancer-from-a-large-multigene-panel-tested-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-sph4336-plus-endocrine-therapy-in-hr-positiveher2-negative-metastatic-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evolution-of-immune-checkpoint-inhibitor-trials-in-oncology-from-2011-to-2025-a-cross-sectional-stu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-ai-based-quantitative-b7-h3-evaluation-in-the-tumor-microenvironment-with-molecular-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinico-genomic-landscape-and-prognostic-impact-of-apcctnnb1-oncogenic-alterations-in-non-small-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-baseline-severe-cytopenia-on-post-bcma-car-t-cell-therapy-outcomes-in-multiple-myeloma-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-clinical-impact-and-prognostic-utility-of-circulating-tumor-dna-in-stage-i-iv-non-small-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-patterns-of-lung-cancer-among-psychoactive-substance-using-older-adults-in-the-united-sta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-disseminated-intravascular-coagulation-on-in-hospital-outcomes-in-patients-with-multiple-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-results-with-ima401-a-magea48-targeted-t-cell-receptor-based-bispecific-t-cell-enga 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-landscape-and-patient-demographics-in-endocervical-adenocarcinoma-insights-from-the-aacr-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sequencing-strategy-of-immunotherapy-with-chemoradiotherapy-in-stage-iii-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/consolidated-pd-l1-inhibitors-after-chemoradiotherapy-versus-placebo-in-non-resectable-non-small-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/update-of-the-eortc-qlq-ovarian-cancer-module-eortc-qlq-ov28-phase-i-and-ii 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phasex-as-a-phase-09-translational-platform-to-de-risk-bite-immunotherapy-through-mechanistic-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surgical-outcomes-of-sleeve-versus-standard-lobectomy-in-patients-with-non-small-cell-lung-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-sacituzumab-govitecan-in-patients-with-muscle-invasive-bladder-cancer-final-results-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/organ-specific-metastatic-progression-in-non-small-cell-lung-cancer-treated-with-pembrolizumab-versu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/socioeconomic-and-treatment-related-determinants-of-long-term-cancer-survival-a-population-based-se 2026-08-24 monthly 0.7 https://rjrindex.com/articles/contribution-of-atezolizumab-atezo-to-the-efficacy-of-the-zanzalintinib-zanza-atezo-combinatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-early-on-treatment-coordinated-inflammatory-niche-plasma-signature-as-a-predictor-of-response-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-breast-density-reporting-on-supplemental-mri-and-ultrasound-use 2026-08-24 monthly 0.7 https://rjrindex.com/articles/post-prophylaxis-cmv-in-the-letermovir-era-incidence-risk-factors-and-outcomes-following-hct 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-lisocabtagene-maraleucel-liso-cel-in-patients-pt-with-relapsed-or-refract 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-and-timing-of-palliative-care-consultation-in-patients-with-newly-diagnosed-metastatic-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-oral-and-genital-hpv-45-and-non-vaccine-targeted-hpv-35-among-us-adults 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cfdna-wgs-vs-plasma-proteomics-for-minimally-invasive-mrd-assessment-in-multiple-myeloma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterizing-the-genomic-landscape-of-langerhans-cell-histiocytosis-using-the-aacr-project-genie-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/allele-specific-targeting-of-cd33-as-a-novel-approach-to-enhance-car-t-selectivity-in-relapsed-acute 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interrogation-of-fibrolamellar-cancer-to-provide-clinically-relevant-insights-into-therapeutic-vulne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/follow-up-of-outpatients-taking-oral-anticancer-drugs-in-the-multidisciplinary-community-hospital-on 2026-08-24 monthly 0.7 https://rjrindex.com/articles/remote-activity-monitoring-to-detect-physical-function-decline-and-unexpected-medical-events-in-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enterprise-wide-implementation-of-multicancer-detection-testing-across-a-large-academic-health-syste 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prenatal-hormonal-imprinting-reflected-by-anogenital-distance-and-risk-of-breast-cancer-a-case-cont 2026-08-24 monthly 0.7 https://rjrindex.com/articles/non-operative-management-in-mismatch-repair-deficient-dmmr-esophagogastric-cancer-egc-following 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiology-of-early-onset-colorectal-cancer-in-the-who-eastern-mediterranean-region-regional-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/feasibility-of-constructing-an-external-control-arm-for-early-efficacy-assessment-in-phase-1a-metho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficient-machine-learning-for-pulmonary-nodule-classification-on-computed-tomography-a-lightweight 2026-08-24 monthly 0.7 https://rjrindex.com/articles/e-pros-in-oncology-improving-treatment-adherence-to-treatment-while-reducing-emergency-care-and-cos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-gut-microbiota-and-peri-initiation-proton-pump-inhibitorantibiotic-exposure-with-out 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathologic-features-treatment-patterns-and-outcomes-in-young-women-with-metastatic-breast-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-risk-stratification-schema-for-patients-with-non-small-cell-lung-cancer-with-multiple-organ-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/communication-of-tumor-testing-and-molecular-results-to-patients-and-caregivers-in-glioblastoma-a-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transfusion-effectiveness-and-clinical-outcomes-in-acute-leukemia-do-poor-responders-have-worse-out 2026-08-24 monthly 0.7 https://rjrindex.com/articles/siltuximab-for-the-prevention-of-severe-immune-related-adverse-events-during-immune-checkpoint-inhib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fern-ec-01-bnt323-01-a-phase-3-trial-of-trastuzumab-pamirtecan-her2-adc-versus-investigators-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/donafenib-plus-transarterial-chemoembolization-tace-with-or-without-anti-pd-1-antibodies-for-unres 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trial-growth-and-accessibility-enrollment-weighted-access-to-us-lung-cancer-clinical-trials-2015 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bone-marrow-immune-cell-state-analysis-and-selective-apc-alterations-in-prolonged-cytopenia-followin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-study-of-metronomic-cyclophosphamide-with-pembrolizumab-in-checkpoint-inhibitor-refractory-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iiia-dose-escalation-dose-optimization-and-dose-expansion-study-to-evaluate-the-safety-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiology-nlp-derived-real-world-progression-endpointing-and-clinicogenomic-correlates-after-177lu-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artemide-biliary02-a-phase-3-randomized-global-study-of-rilvegostomig-or-durvalumab-with-chemothe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/xalience-a-phase-3-open-label-multicenter-randomized-study-of-xaluritamig-plus-abiraterone-vs-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/indurans-a-randomized-phase-ii-trial-on-induction-immunochemotherapy-followed-by-surgery-or-chemora 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iii-clinical-study-of-doc1021-dubodencel-dendritic-cell-immunotherapy-for-refractory-mela 2026-08-24 monthly 0.7 https://rjrindex.com/articles/proteogenomic-profiling-of-gallbladder-cancer-for-identification-of-distinct-biology-and-subtype-spe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adoption-and-inpatient-outcomes-of-chimeric-antigen-receptor-t-cell-therapy-in-lymphomas-and-leukemi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iia-open-label-multi-center-study-of-the-dna-polymerase-theta-inhibitor-art6043-administered 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparative-outcomes-of-first-generation-versus-second-and-third-generation-tyrosine-kin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-usability-of-a-clinical-trial-knowledge-platform-in-a-community-cancer-network 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combining-zanidatamab-folfox-and-pembrolizumab-as-first-line-therapy-for-her2pd-l1-positive-gastr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alpha-emitting-radionuclide-or-beta-emitting-radionuclide-combined-with-metastasis-directed-stereota 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-with-brexucabtagene-autoleucel-in-refractory-mantle-cell-lymphoma-a-systematic-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/heterogeneity-of-interim-pet-partial-metabolic-response-in-dlbcl-risk-stratification-using-dsuvmax 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-maintenance-therapy-patterns-in-ibrcai-wild 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-and-safety-of-neoadjuvant-pembrolizumab-in-early-stage-triple-negative-breast-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-immune-therapy-based-regimens-in-sarcomatoid-lung-cancer-a-systematic-review-and-meta-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-solid-basaloid-and-classic-adenoid-cystic-carcinoma-of-the-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevention-of-paclitaxel-induced-peripheral-neuropathy-using-limb-cryotherapy-evidence-from-a-resou 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-geographic-disparities-in-hodgkin-lymphoma-mortality-among-adolescents-and-young-adults-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-treatment-patterns-and-outcomes-of-patients-with-small-bowel-cancer-a-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/brain-metastases-in-her2-positive-metastatic-gastrointestinal-cancers-incidence-timing-and-impli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-a-large-language-model-generated-after-visit-summary-from-outpatient-hematologyoncolo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/three-decades-of-breast-cancer-predisposition-genetic-testing-at-a-comprehensive-cancer-center 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-ongoing-phase-1-2a-study-of-eo1001-an-oral-brain-penetrant-pan-erbb-inhibitor-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/envafolimab-kn035-plus-gemcitabine-and-oxaliplatin-gemox-compared-with-gemox-as-first-line-treat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-characteristics-treatment-patterns-and-outcomes-of-newly-diagnosed-diffuse-large-b-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-effectiveness-of-advanced-radiofrequency-ablation-electrode-systems-for-hepatocellular-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-and-disparities-in-gallbladder-cancer-mortality-a-us-population-based-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-g8-screening-and-carg-toxicity-scores-to-predict-emergency-room-er-hospital-ip-admission 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-predictors-of-survival-and-disease-progression-in-melanoma-a-real-world-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neighborhood-deprivation-and-nativity-in-breast-cancer-stage-at-diagnosis-among-us-and-latin-amer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncology-social-work-outreach-as-a-predictor-of-oncology-appointment-completion-among-cancer-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/performance-of-premmplus-in-a-racially-and-ethnically-heterogenous-population-undergoing-germline-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-neighborhood-effects-and-geographic-embeddings-in-random-forest-modeling-of-mammography-scre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sociodemographic-factors-and-delays-in-care-for-gestational-trophoblastic-neoplasia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hospital-volume-travel-burden-and-survival-disparities-in-stage-iv-melanoma-a-us-national-cohor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gastric-cancer-outcomes-in-adolescents-and-young-adults-in-alberta-canada 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-cancer-survivor-perspectives-on-nutrition-results-of-a-comprehensive-survey 2026-08-24 monthly 0.7 https://rjrindex.com/articles/myoepithelial-carcinoma-defining-natural-history-and-therapeutic-outcomes-in-a-rare-malignancy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/malignant-hemangiopericytoma-a-national-cancer-database-study-of-demographic-and-socioeconomic-fact 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-analysis-of-cd8-t-cell-neighbors-using-multiplexed-immunofluorescence-mxif-in-esophageal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-extracolonic-cancers-in-individuals-with-lynch-syndrome-a-canadian-population-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-data-platform-backbone-of-cancer-research-office 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ocular-cancer-and-inpatient-thrombotic-phenotypes-associations-with-retinal-vascular-occlusions-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognosis-of-mediastinal-lymph-node-metastases-in-pediatric-patients-with-osteosarcoma-and-lung-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/myoepithelial-carcinoma-a-national-cancer-database-study-of-demographic-and-socioeconomic-factors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-survival-for-rural-and-urban-populations-during-the-opioid-epidemic-a-seer-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-rna-sequencing-on-diagnosis-and-therapy-early-results-from-a-tertiary-cancer-center-in-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dietary-changes-in-head-and-neck-cancer-patients-pre-and-post-chemotherapy-andor-radiation-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-effect-of-perioperative-radiotherapy-on-prognosis-in-patients-with-operable-rectal-cancer-who-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bcg-at-home-a-first-in-kind-pilot-trial-of-home-based-intravesical-bacillus-calmette-guerin-deliver 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-and-clinical-outcomes-in-patients-with-triple-negative-breast-cancer-tnbc-and-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/knowledge-and-uptake-of-hpv-vaccination-among-hispanic-women-and-vaccine-eligible-children 2026-08-24 monthly 0.7 https://rjrindex.com/articles/failure-to-rescue-after-acute-cardiac-events-in-cancer-versus-non-cancer-hospitalizations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bone-health-and-antiresorptive-agent-use-in-asian-american-pacific-islander-aapi-women-with-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/remote-scalable-weight-loss-interventions-after-early-stage-breast-cancer-a-systematic-review-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/arterial-and-venous-thromboembolic-events-in-ialki-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/digital-delivery-of-personalized-cancer-risk-reduction-real-world-engagement-with-acs-cancerrisk360 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-socioeconomic-vulnerability-and-treatment-delivery-in-patients-receiving-oral-antic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-of-hmgb1-expression-as-a-biomarker-of-immunogenic-cell-death-in-patients-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-chemotherapy-in-patients-with-grade-2-or-3-appendiceal-cancer-undergoing-cytoreductive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-bidirectional-cohort-study-of-chemotherapy-targeted-alternating-therapy-on-outcomes-of-third-line 2026-08-24 monthly 0.7 https://rjrindex.com/articles/melanoma-stage-as-influenced-by-31-gep-risk-prediction 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-ncdb-analysis-on-the-demographic-treatment-and-survival-of-seromucinous-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-related-adverse-events-with-immune-checkpoint-inhibitors-insights-from-real-world-practice-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-study-of-vlponc-01-a-novel-il-12-encoding-sarna-viral-replicon-particle-alone-and-in-combi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combination-of-tulmimetostat-and-pd-1-blockade-for-patients-with-advanced-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/petosemtamab-plus-pembrolizumab-as-first-line-1l-treatment-of-pd-l1-high-metastatic-non-small-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrin-a-subvsub-v-sub3sub 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glp-1-therapy-and-hormone-receptor-positive-breast-cancer-risk-and-survival-a-real-world-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-interpreting-circulating-tumor-dna-guided-risk-stratification-after-first-line-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathologic-treatment-effect-and-first-recurrence-behavior-after-curative-liver-surgery-for-hcc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ep4-antagonist-ono-4578-plus-nivolumab-and-chemotherapy-in-her2-negative-unresectable-advanced-or-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-of-the-chemotherapy-free-regimen-of-blinatumomab-and-ponatinib-in-patients-with-newl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploratory-associations-between-incretin-based-therapies-and-plasma-cell-disorders-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-from-inmmycar-the-ongoing-first-in-human-phase-1-study-of-kln-1010-in-patients-pts 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-recurrence-risk-in-stage-iibc-melanoma-across-time-implications-for-stratification-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-results-of-tazemetostat-in-japanese-patients-with-advanced-epithelioid-sarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-bat8006-in-combination-with-bat1308-in-patients-with-advanced-endometrial-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-trial-of-androgen-deprivation-therapy-interruption-in-patients-responding-exceptionally-to 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-a-weight-loss-intervention-wli-on-quality-of-life-qol-and-symptoms-in-women-with-breas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-treatment-of-qls31905-plus-chemotherapy-in-patients-with-pancreatic-cancer-and-gastric-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-classifier-driven-nccn-risk-reclassification-to-track-distinct-transcriptomic-signatures-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ringside-a-phase-3-randomized-placebo-controlled-trial-of-varegacestat-for-treatment-of-progressin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/swivel-a-randomized-phase-ii-trial-of-switching-medications-versus-guideline-directed-interventions 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epigenetic-profiling-to-identify-aggressiveness-markers-in-non-hodgkin-lymphoma-via-a-targeted-methy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/benefit-of-adjuvant-therapy-in-high-risk-gist-a-large-scale-real-world-analysis-of-2166-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/modern-hodgkin-lymphoma-treatments-to-reduce-second-cancer-risks-influence-of-risk-adapted-screenin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-accuracy-of-circulating-tumor-dna-for-post-remission-surveillance-in-diffuse-large-b-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-comparing-sequencing-of-car-t-followed-by-bite-versus-bite-followed-by-car-t-in-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/variants-of-uncertain-significance-and-contralateral-risk-reducing-mastectomy-in-early-stage-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-responders-to-trifluridinetipiracil-plus-bevacizumab-in-previously-treated-metastatic-col 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-factors-and-long-term-prognostic-impact-of-trastuzumab-deruxtecan-related-interstitial-lung-dis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/belzutifan-in-docetaxel-pretreated-metastatic-castration-resistant-prostate-cancer-mcrpc-phase-1b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-trends-and-disparities-in-prostate-cancer-with-co-occurring-cardiometabolic-disorders-amon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pulmonary-immune-related-adverse-events-post-immune-checkpoint-inhibitors-ici-real-world-experien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-study-of-cavitation-enhanced-drug-delivery-ceedd-by-sonosensitive-particles-and-foc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dynamic-biological-and-metabolic-response-by-ebv-dna-and-sup18sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-combination-study-of-galunisertib-and-capecitabine-in-patients-with-chemotherapy-resistan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/allostatic-load-as-a-mediator-of-exposomic-risk-pathways-to-early-onset-cancer-a-cross-cohort-valid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prediction-of-localized-rectal-cancer-outcomes-with-ctdna-analysis-using-a-novel-ultrasensitive-stru 2026-08-24 monthly 0.7 https://rjrindex.com/articles/barriers-and-variability-in-lymphedema-therapy-for-head-and-neck-cancer-survivors-secondary-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-and-adjuvant-enfortumab-vedotin-plus-pembrolizumab-for-participants-with-muscle-invasive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ib-open-label-clinical-trial-of-jab21822-combined-with-second-line-chemotherapy-for-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reduced-oxaliplatin-exposure-in-gastrointestinal-cancers-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ischemic-heart-disease-as-a-competing-cause-of-death-among-patients-with-lung-cancer-in-the-united-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-clinical-and-molecular-characterization-of-wnt-pathway-alterations-in-metastatic-castrati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-pemetrexed-and-pembrolizumab-in-patients-pts-with-recurrent-andor-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunogenicity-profiles-in-pediatric-extra-cranial-rhabdoid-tumors-a-framework-for-future-risk-stra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/durvalumab-plus-chemotherapy-prior-to-chemoradiotherapy-and-followed-by-durvalumab-as-consolidation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-determinants-of-survival-after-biliary-tract-cancer-resection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-phase-i-open-label-multicenter-study-of-hj-004-a-novel-egfr-protac-degrader-in-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-internal-medicine-residents-confidence-in-oncology-goals-of-care-conversations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sigvie-003-phase-3-trial-of-frontline-sigvotatug-vedotin-plus-pembrolizumab-vs-pembrolizumab-alone 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adaptive-phase-23-study-of-eik1001-a-tlr78-dual-agonist-in-combination-with-pembrolizumab-as-fi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-open-label-trial-of-neoadjuvant-immunotherapy-in-combination-with-capox-for-resectable-non 2026-08-24 monthly 0.7 https://rjrindex.com/articles/developing-an-integrated-survivorship-checklist-for-lmic-feasibility-and-results-from-a-tertiary-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-incidence-and-mortality-in-biliary-tract-cancers-in-the-united-states-2000-2023 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-multi-center-clinical-trial-evaluating-the-safety-pharmacokinetics-pharmacodynamics-and-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/symbiotic-gi-03-a-randomized-double-blind-phase-3-study-of-first-line-pf-08634404-a-pd-1vegf-bi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-23-trial-of-pumitamig-pd-l1-vegf-a-bsab-plus-chemotherapy-versus-bevacizumab-plus-chemoth 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rethinking-infection-prevention-after-modern-cll-and-nhl-therapy-a-real-world-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-donafenib-combined-with-hepatic-artery-infusion-chemotherapy-and-sintilimab-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/kite-753-a-phase-2-study-of-an-autologous-anti-cd19cd20-car-t-cell-therapy-in-car-naive-patients-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-ql1706-based-combination-therapy-in-recurrent-or-metastatic-endometrial-carci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sensory-neuropathy-and-neuropathic-pain-during-taxane-chemotherapy-in-cipn-free-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-cemiplimab-plus-cetuximab-prior-to-salvage-surgery-for-recurrent-oral-cavity-squamous-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-study-of-ubamatamab-regn4018-a-muc16cd3-bispecific-antibody-administered-alone-or-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iii-multicenter-randomized-non-inferiority-trial-comparing-selective-versus-modified-neck-di 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stereotactic-body-radiotherapy-sbrt-combined-with-pd-1-inhibitor-and-chemotherapy-in-early-stage-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beamion-lung-3-zongertinib-in-resectable-iher2i-mutan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/projected-burden-of-lung-cancer-and-pneumonia-among-older-adults-in-the-united-states-a-cdc-wonder 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-value-of-ctdna-based-mrd-combined-with-pet-ct-and-gastroscopy-for-treatment-efficacy-in-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/moving-the-surgical-prostate-cancer-treatment-to-value-early-results-in-patient-reported-outcomes-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-gpd1l-in-colorectal-cancer-progression-a-systematic-review-of-its-expression-molecular 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-associated-with-delays-in-treatment-initiation-and-interruptions-in-head-and-neck-squamous-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/foundation-models-to-bridge-the-data-scarcity-and-explainability-gap-in-pancreatic-cancer-diagnosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nationwide-oncologist-survey-on-biomarker-integration-and-evidence-based-gastricgej-cancer-care-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sociodemographic-predictors-of-palliative-care-utilization-across-a-mid-atlantic-healthcare-system 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burden-of-heart-failure-related-mortality-among-us-adults-with-leukemia-1999-2023 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-procedural-position-of-multi-cancer-early-detection-mced-in-cancer-screening-paradigm-a-simul 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-latency-interval-on-survival-in-second-primary-malignancies-after-head-and-neck 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utility-of-sacubitrilvalsartan-in-the-prevention-of-cancer-therapy-related-cardiac-dysfunction-ctr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-chemoimmunotherapy-before-chemoradiation-vs-chemoradiation-alone-for-stage-iib-iiic1-car 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regenovar-a-phase-iii-study-of-ubamatamab-plus-carboplatin-paclitaxel-and-bevacizumab-as-salvage 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-amivantamab-hyaluronidase-in-imeti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-experience-with-later-line-chemotherapy-in-four-tumor-types 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-care-and-long-term-survival-in-metastasizing-ameloblastoma-an-ncdb-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cholangiocarcinoma-care-across-america-a-tale-of-two-coasts 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-variation-in-thromboprophylaxis-models-of-care-and-implementation-supports-for-hospitalized-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/open-laparoscopic-versus-robotic-surgery-for-siewert-type-iiiii-adenocarcinoma-of-esophagogastric 2026-08-24 monthly 0.7 https://rjrindex.com/articles/modified-soluble-interleukin-2-receptor-to-ferritin-ratio-for-diagnosis-of-lymphoma-associated-hemop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-and-disparities-in-gallbladder-cancer-mortality-in-the-united-states-1999-2023 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-phase-2-trial-of-ruxolitinib-in-combination-with-radiation-and-temozolomide-compared-to-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-cost-per-month-of-response-for-olutasidenib-olu-versus-ivosidenib-ivo-for-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fruquintinib-in-combination-with-camrelizumab-paclitaxel-liposome-and-nedaplatin-as-first-line-tre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-tyrosine-kinase-inhibitors-as-a-post-hematopoietic-stem-cell-transplant-maintenance-ther 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-regimen-of-liposomal-irinotecan-plus-capecitabine-as-total-neoadjuvant-therapy-for-locally-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/penpulimab-ak105-combined-with-cetuximab-as-first-line-treatment-in-recurrentmetastatic-head-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tucatinib-subcutaneous-sc-trastuzumab-tuc-trast-sc-in-patients-pts-with-solid-tumors-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stage-dependent-metabolic-reprogramming-in-treatment-naive-lung-adenocarcinoma-from-oxidative-flexi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-epigenomic-profiling-of-plasma-for-non-invasive-detection-of-met-activation-to-uncover 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-academic-center-based-care-on-clinical-outcomes-in-light-chain-amyloidosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-1000-patients-report-of-global-practice-patterns-and-clinical-outcomes-in-the-collaborative-oc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/admission-acuity-and-inpatient-outcomes-among-hospitalizations-for-pancreatic-cancer-in-the-united-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-pathological-outcomes-of-patients-with-germ-cell-tumor-undergoing-surgical-resection-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementing-clinical-scale-multiscale-spatial-transcriptomics-tumor-architecture-profiling-in-scru 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-dual-immune-checkpoint-inhibitors-ici-by-the-time-of-infusion-in-advanced-non-small-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-surgical-resection-combined-with-intraoperative-cesium-131-brachytherapy-in-brain-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-inpatient-radiation-for-central-nervous-system-cns-tumors-timing-predictors-and-in-hospit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-proteogenomic-profiling-to-reveal-prognostic-subtypes-and-actionable-targets-in-adenoid-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/institutional-disparities-in-actionable-mutation-detection-in-pancreatic-ductal-adenocarcinoma-an-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-of-new-keratinocyte-cancers-during-pembrolizumab-in-resectable-cutaneous-squamous-cell-car 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1b-study-of-a-brain-penetrant-mek-inhibitor-pf-07799544-plus-next-generation-braf-dimer-inhi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-pd-1-versus-pd-l1-inhibitors-combined-with-chemotherapy-as-first-line-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nivolumab-plus-ipilimumab-with-chemotherapy-as-first-line-therapy-for-nsclc-a-single-center-real-wo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-performance-of-novel-exosomal-liquid-rna-biopsy-assay-in-breast-cancer-segment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-experience-with-t-cell-receptor-cellular-therapy-in-advanced-solid-malignancies-a-multi-cente 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-duration-of-bone-targeting-agent-on-adverse-events-aes-and-skeletal-related-events-sre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rad-sg-adaptive-radiation-therapy-with-concurrent-sacituzumab-govitecan-for-bladder-preservation-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-sepsis-related-mortality-among-patients-with-lung-cancer-a-25-year-nation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-the-navya-earthshot-enabled-clinical-decision-support-system-on-treatment-turnaround-time 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-and-frailty-analyses-of-transplant-ineligible-tie-patients-pts-with-newly-diagnosed-multiple 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-social-vulnerability-on-end-of-life-care-in-hematologic-malignancies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/who-even-talks-to-her-anymore-misalignment-between-cervical-cancer-care-landscape-and-community-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-effects-of-the-covid-19-pandemic-on-cancer-incidence-and-cancer-specific-mortality 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-nab2-stat6-distal-fusion-with-risk-level-of-metastatic-disease-and-thoracic-primary-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/operational-and-clinical-drivers-of-subcutaneous-pd-1pd-l1-inhibitor-adoption-a-mixed-methods-anal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/non-random-patterns-of-multiple-primary-malignancies-in-the-era-of-cancer-survival 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enabling-blood-based-mass-spectrometry-mrd-detection-in-multiple-myeloma-without-archived-serum-samp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-follow-up-after-identification-of-variants-of-uncertain-significance-in-highly-penetran 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-onset-gastrointestinal-cancers-racial-disparities-in-stage-and-survival-from-large-scale-comm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-efficacy-and-immunogenicity-of-adjuvant-therapy-with-personalized-cancer-vaccine-pcv-rgl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-combined-t-cell-and-nk-cell-activity-in-immune-checkpoint-inhibitor-ici-therapy-in-end 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pseudoprogression-after-neoadjuvant-immunotherapy-for-resectable-nsclc-incidence-petct-patterns 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glp-1-receptor-agonist-utilization-and-survival-outcomes-in-a-large-us-community-oncology-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-incidence-survival-and-cause-of-death-in-kaposi-sarcoma-in-the-antiretroviral-therapy-er 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-ctdna-from-a-phase-ii-study-of-adjuvant-dostarlimab-with-pelvic-radiation-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-external-validation-of-the-immotion151-molecular-subtypes-in-patients-with-advanced-renal-cell-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oral-mannitol-for-chemotherapy-induced-constipation-cic-a-randomized-multicenter-controlled-stu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-genomic-predictors-of-outcomes-in-patients-pts-with-advanced-urothelial-carcinoma-au 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-duration-with-avutometinibdefactinib-in-recurrent-low-grade-serous-ovarian-carcinoma-by-k 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erythrocyte-anti-pd-1-conjugates-in-patients-with-advanced-solid-tumors-resistant-to-anti-pd-1pd-l1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-il7-on-immtac-mediated-killing-by-t-cells-in-vitro-and-t-cell-fitness-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/5-aminolevulinic-acid-fluorescence-guided-surgery-vs-conventional-white-light-resection-in-glioma-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/knowledge-distilled-efficientnets-for-peripheral-blood-smear-classification 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-trends-and-demographic-disparities-in-renal-cell-carcinoma-mortality-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-ctdna-reassessment-ltctdna-in-nsclc-immunotherapy-responders 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liposomal-irinotecan-plus-cisplatincarboplatin-as-second-line-therapy-for-platinum-sensitive-relaps 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-durvalumab-with-or-without-tremelimumab-in-metastatic-nsclc-a-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/management-of-pancreatic-metastases-from-renal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-with-first-line-platinum-etoposide-plus-durvalumab-versus-platinum-etoposide-alone 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-pcsk9-inhibitors-with-clinical-outcomes-in-patients-with-cancer-receiving-immune-chec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cohort-level-safety-and-efficacy-results-for-sup212sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fixed-duration-subcutaneous-sc-mosunetuzumab-mosun-in-elderlyunfit-patients-with-previously-unt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gdf-15-levels-and-clinical-correlates-in-head-and-neck-cancer-patients-developing-a-risk-model-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-of-serum-microrna-371a-3p-testing-for-testicular-germ-cell-tumors-in-a-pathology-depa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-baseline-demographics-on-therapy-management-in-patients-pts-with-metastatic-castration-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-impact-of-atrial-fibrillation-afib-on-cardiovascular-cv-outcomes-and-healthcare-resou 2026-08-24 monthly 0.7 https://rjrindex.com/articles/defining-when-and-how-to-support-palliative-care-communication-international-consensus-on-timing-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/thromboelastography-guided-platelet-transfusion-and-associations-with-utilization-and-outcomes-in-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-controlled-trial-of-a-multilingual-digital-genetic-cancer-risk-assessment-tool-in-a-div 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-the-taylor-cancer-research-center-tcrc-and-tempus-ai-time-partnership-on-clinical-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/toxicity-risk-calculator-for-personalised-prediction-of-iraes-in-patients-with-solid-tumours-receivi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/non-invasive-characterization-of-intratumoral-cd8-t-cells-using-standard-of-care-soc-ct-and-89zr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liposomal-irinotecan-combined-with-oxaliplatin-5-fluorouracilleucovorin-with-or-without-camrelizum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-eftilagimod-alfa-an-apc-activator-via-mhc-class-ii-on-lymphocyte-activation-and-survival 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-radiomics-based-model-for-the-prediction-of-whoisup-in-clear-cell-renal-cell-carcinoma-using-cont 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surgical-de-escalation-in-high-risk-resectable-melanoma-with-major-pathologic-response-mpr-after-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-sex-based-disparities-in-pancreatic-cancer-clinical-trial-enrollment-a-systematic-review-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prth-101-an-investigational-treatment-for-thoracic-solid-tumors-targeting-discoidin-domain-receptor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-context-constrained-oncology-agent-for-automated-guideline-concordant-treatment-decision-support 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-sars-cov-2-vaccination-with-survival-outcomes-in-patients-with-metastatic-solid-tumor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-value-in-the-age-of-accelerated-approval-a-pembrolizumab-case-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-analysis-of-the-tinivo-2-phase-3-trial-long-term-outcome-of-tivozanib-tivo-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-basket-study-of-telisotuzumab-adizutecan-temab-a-abbv-400-a-c-met-protein-targeting-anti-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-a-preoperative-pathological-risk-prediction-model-for-thymic-tumors-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/indefinite-versus-2-years-fixed-duration-of-immune-checkpoint-inhibition-in-metastatic-non-small-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-the-combination-of-regorafenib-avelumab-in-patients-with-hpv-associated-cancer-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-re-adoption-of-open-radical-hysterectomy-on-postoperative-outcomes-in-the-united-state 2026-08-24 monthly 0.7 https://rjrindex.com/articles/t-cell-stem-like-memory-cells-as-a-novel-biomarker-to-identify-patients-with-sustained-disease-contr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/iatmi-mutations-in-pancreatic-cancer-a-real-world-analysis-of-molecular-la 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nivolumab-plus-lenvatinib-for-unresectable-anaplastic-thyroid-cancer-results-of-the-phase-2-navigat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-survival-disparities-and-future-burden-of-multiple-myeloma-a-population-based-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/when-im-translating-im-a-daughter-as-well-perspectives-of-caregivers-supporting-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-clinical-prediction-score-to-identify-symptomatic-patients-at-high-risk-for-colorectal-cancer-in-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hallmarks-of-cancer-in-stage-ii-iii-nsclc-treated-with-chemoradiotherapy-crt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-interpretable-machine-learning-model-using-routine-clinicopathological-variables-to-predict-posto 2026-08-24 monthly 0.7 https://rjrindex.com/articles/initial-findings-from-the-promise-registry-a-us-decentralized-prospective-prostate-cancer-genetic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-efficacy-and-safety-of-first-line-pd-1-inhibitors-plus-metronomic-oral-vinorelbine-in-elderl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-novel-anti-cancer-drug-by-locking-inhibition-of-amino-acid-transporter-lat1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/t320-tissue-factor-targeted-adc-from-pre-clinical-research-to-phase-i-clinical-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-large-language-models-to-extract-diagnosis-recurrence-and-death-dates-from-breast-cancer-ele 2026-08-24 monthly 0.7 https://rjrindex.com/articles/doctor-am-i-cured-characteristics-of-long-term-survivors-with-advanced-melanoma-treated-with-immun 2026-08-24 monthly 0.7 https://rjrindex.com/articles/two-decades-of-change-trends-and-disparities-in-breast-cancer-surgical-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/endometrial-cancer-mortality-and-persistent-disparities-in-the-united-states-1999-2023 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-risk-stratification-in-a-us-based-database-to-identify-subgroups-of-patients-with-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-relacorilant-and-nab-paclitaxel-in-platinum-resistant-ovarian-cancer-a-grade 2026-08-24 monthly 0.7 https://rjrindex.com/articles/discharge-trajectories-and-30-day-readmission-risk-in-hospitalized-breast-cancer-patients-with-malig 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-use-of-complementary-and-alternative-medicine-in-the-middle-east-for-managing-neutropenia-in-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/colorectal-cancer-with-hypertension-among-middle-aged-and-older-adults-in-united-states-1999-2023 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-ripretinib-on-the-pharmacokinetics-pk-of-repaglinide-a-sensitive-cyp2c8-probe-substrate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-clinical-characteristics-of-patients-with-t1114-positive-multip 2026-08-24 monthly 0.7 https://rjrindex.com/articles/myxoid-leiomyosarcoma-a-population-based-ncdb-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-affecting-outcomes-in-early-onset-vs-average-onset-head-and-neck-cancers-a-multicenter-retr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-enzymatic-component-of-the-nitric-oxide-system-in-mitochondria-of-melanoma-and-skin-what-change 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-and-regional-variation-of-cervical-cancer-in-nigeria-a-systematic-review-and-meta-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-cardiovascular-mortality-among-ovarian-cancer-patients-in-the-united-states-a-22 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiotherapy-followed-by-capox-plus-tislelizumab-in-microsatellite-stable-rectal-cancer-with-synchro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/uterine-serous-and-clear-cell-carcinomas-hormonal-profile-and-expression-of-steroid-hormone-recepto 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-ultrasensitive-ddpcr-and-ngs-for-circulating-tumor-hpv-dna-in-minimal-residual-disease 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-use-of-regorafenib-for-refractory-metastatic-colorectal-cancer-survival-outcomes-and-ass 2026-08-24 monthly 0.7 https://rjrindex.com/articles/translating-real-world-data-into-actionable-insights-an-ai-powered-model-for-prostate-cancer-surviv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-observational-study-to-investigate-the-effectiveness-and-safety-of-niraparib-maintenance-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/malnutrition-as-a-hidden-driver-of-inpatient-mortality-in-gastrointestinal-cancer-a-national-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-of-body-fat-in-early-stage-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-clinical-and-dosimetric-study-on-the-feasibility-and-adaptability-of-mr-linac-in-the-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/are-patient-reported-outcome-measures-valid-across-diverse-cancer-populations-a-review-of-psychome 2026-08-24 monthly 0.7 https://rjrindex.com/articles/derivation-and-external-validation-of-a-prognostic-nomogram-for-her2-negative-early-breast-cancer-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/terminal-admission-phenotypes-and-inpatient-mortality-in-gastrointestinal-malignancies-a-national-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/novel-isocryptolepine-analogs-with-submicromolar-antiproliferative-activity-en-route-to-next-in-cla 2026-08-24 monthly 0.7 https://rjrindex.com/articles/socioeconomic-and-access-disparities-in-ovarian-cancer-treatment-and-outcomes-a-retrospective-cohor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/strategic-alignment-of-quality-improvement-interventions-to-address-barriers-to-adult-vaccination-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/timing-of-biomarker-testing-and-associated-clinical-outcomes-in-ovarian-cancer-patients-a-retrospec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-study-to-evaluate-safety-tolerability-and-pharmacokinetics-of-lnp8701-sos1-inhibitor-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perception-and-awareness-of-cancer-immunotherapy-among-healthcare-professionals-and-students-at-a-te 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sensitivity-of-ca-125-by-ovarian-cancer-histology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/upfront-ultrafast-multigene-panel-testing-for-nccn-guideline-recommended-biomarker-detection-in-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-importance-of-family-history-in-indicating-hboc-genetic-testing-in-a-resource-limited-setting 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-cardiovascular-outcomes-with-gnrh-agonist-and-antagonist-therapy-in-non-metastatic-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lattice-sfrt-combined-with-systemic-therapy-for-bulky-unresectable-hepatocellular-carcinoma-a-retro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-evaluation-of-a-dark-kinase-based-transcriptional-score-in-acute-myeloid-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/determinants-of-recurrence-after-curative-gastrectomy-in-young-onset-gastric-cancer-a-latin-america 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-trilaciclib-against-chemotherapy-induced-myelosuppression-an-updated-systematic-review-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-internal-validation-of-a-web-based-risk-assessment-tool-for-chemotherapy-induced-per 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-anlotinib-and-sintilimab-combined-with-gemox-in-advanced-combined-hepatocellu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-secondary-hematologic-malignancies-with-radioactive-iodine-therapy-for-differentiated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcome-of-asian-and-non-hispanic-white-patients-with-colorectal-cancer-in-a-nci-designated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/eunetccc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/is-the-accelerator-working-an-updated-empirical-analysis-of-fda-accelerated-approvals 2026-08-24 monthly 0.7 https://rjrindex.com/articles/late-hematological-toxicity-after-chemotherapy-exome-analysis-with-long-term-follow-up-in-mexican-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-pre-existing-chronic-kidney-disease-with-in-hospital-mortality-and-resource-utilizati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prompt-engineering-and-readability-of-large-language-model-generated-patient-education-materials-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-racial-and-age-disparities-in-response-and-survival-among-acute-myeloid-leukemia-aml 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-feasibility-and-hematologic-toxicity-of-induction-chemotherapy-in-advanced-cervical-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-systemic-therapy-in-patients-with-anaplastic-thyroid-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-with-modern-first-line-systemic-therapy-in-advanced-hepatocellular-carcinoma-a-sy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differentiation-and-stage-as-independent-predictors-of-survival-in-laryngeal-neuroendocrine-carcinom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/drivers-of-non-evaluable-imaging-timepoints-in-oncology-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-application-research-of-the-intervention-program-for-medication-compliance-of-endocr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unintended-access-barriers-how-upper-payment-limit-implementation-may-risk-patient-access 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gastric-cancer-incidence-prevalence-and-mortality-burden-in-the-united-states-retrospective-epide 2026-08-24 monthly 0.7 https://rjrindex.com/articles/response-to-venetoclax-containing-regimens-in-patients-with-relapsedrefractory-rr-t-cell-acute-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1b-two-arm-study-of-tolododekin-alfa-ank-101-in-combination-with-an-anti-pd-1pd-l1-antib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/study-design-of-omaha-015-a-phase-2-basket-study-of-steroidogenesis-inhibitor-opevesostat-in-partic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/design-of-an-innovative-clinical-development-program-using-randomized-controlled-phase-2-trial-data 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tuc-toc-phase-ii-trial-nct05955170-tucatinib-in-combination-with-oral-etoposide-vp16-and-trastu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/body-mass-index-as-a-prognostic-factor-for-trastuzumab-deruxtecan-efficacy-in-advanced-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-atm-as-a-prognostic-biomarker-in-breast-cancer-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhanced-recovery-after-surgery-eras-pathways-in-gynecologic-oncology-a-systematic-review-and-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/deciphering-the-intricate-crosstalk-of-the-efna1-epha3-axis-in-orchestrating-the-proangiogenic-niche 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-metabolic-response-and-circulating-tumor-biomarkers-as-early-indicators-of-therapy-outco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inpatient-outcomes-among-early-onset-breast-cancer-hospitalizations-with-metabolic-dysfunction-assoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/objective-responses-and-survival-outcomes-by-grade-3-4-neutropenia-in-refractory-metastatic-colorect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-dietary-habits-and-lifestyle-in-patients-with-bone-sarcoma-pilot-study-results-of-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-risk-of-interstitial-lung-disease-and-pneumonitis-with-trastuzumab-deruxtecan-vs-trastuzu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/vitiligo-and-alopecia-areata-as-complementary-human-models-of-immune-mediated-melanoma-protection-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/county-level-residential-radon-exposure-testing-patterns-and-cancer-incidence-in-michigan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-incidence-prevalence-and-short-term-outcomes-in-young-onset-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rainfol-03-engot-en-31gog-3128-a-global-phase-3-open-label-randomized-study-of-rinatabart-ses 2026-08-24 monthly 0.7 https://rjrindex.com/articles/carbon-sustain-study-visit-sparing-low-emission-hypofractionated-radiation-therapy-in-a-traffic-de 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-iii-study-of-gemcitabine-plus-cisplatin-with-s-1-versus-gemcitabine-plus-cisplati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-surgery-and-the-type-of-immune-check-point-inhibitors-ici-in-patients-with-locally-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-prevalence-and-temporal-trends-of-colorectal-cancer-across-age-sex-race-and-ethnicity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-versus-delayed-inpatient-radiotherapy-in-head-and-neck-cancer-and-associated-in-hospital-outco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-pd-l1-and-hpv-biomarkers-on-immune-checkpoint-inhibitor-efficacy-in-locally-advanced-hnscc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-role-of-oncologist-type-in-shared-decision-making-for-patients-with-metastatic-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/emerging-trends-in-research-strategies-in-the-first-line-recurrent-or-metastatic-head-and-neck-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-larotrectinib-in-solid-tumors-with-tropomyosin-receptor-kinase-fusion-getne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-ethnic-differences-in-cardiovascular-disease-prevention-and-treatment-amongst-breast-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clear-cell-type-squamous-cell-carcinoma-an-ncdb-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/urban-rural-disparities-in-the-global-south-the-impact-of-urbanicity-on-obesity-comorbidities-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-artificial-intelligence-assistance-on-combined-pd-l1-scoring-on-whole-immunohistochemical 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nutritional-anemia-and-risk-of-critical-illness-among-hospitalized-patients-with-head-and-neck-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-of-cytokine-release-syndrome-in-patients-treated-with-tarlatamab-for-extensive-stage-small-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-immunotherapy-strategies-in-pmmr-advanced-endometrial-cancer-a-network-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-systematic-review-and-meta-analysis-of-artificial-intelligence-assisted-colon-capsule-endoscopy-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/large-scale-emr-based-machine-learning-for-early-risk-stratification-of-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-cancer-mortality-among-adults-with-psychoactive-drug-use-disorders-in-unit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-insurance-based-differences-in-nutritional-anemia-among-hospitalized-patients-with-head-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transfer-of-care-after-virtual-oncology-second-opinions 2026-08-24 monthly 0.7 https://rjrindex.com/articles/race-neighborhood-deprivation-and-mortality-in-prostate-cancer-a-real-world-analysis-from-the-med 2026-08-24 monthly 0.7 https://rjrindex.com/articles/infection-associated-transitions-to-critical-care-level-interventions-in-adult-cancer-hospitalizatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dont-smoke-the-odds-improving-lung-cancer-screening-among-current-smokers-in-east-texas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-multiplex-digital-pcr-based-iesr1i-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alternative-splicing-signatures-to-predict-response-from-hyperthermic-intra-peritoneal-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mammogram-energy-use-metering-to-map-optimization-strategies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiological-trends-and-burden-of-esophageal-cancer-in-the-united-states-1990-2023-a-retrospect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-large-language-models-llms-for-pharmacogenomic-pgx-guided-prescribing-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictivity-of-coagulation-markers-in-diagnosing-acute-promyelocytic-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-and-demographic-trends-in-hypertension-associated-breast-cancer-mortality-in-the-united-sta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/maintenance-therapy-after-induction-chemotherapy-with-anti-egfr-antibody-and-survival-in-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reassessing-neutropenic-vs-liberalized-diets-in-post-chemotherapy-and-hematopoietic-stem-cell-transp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/personality-driven-roles-of-large-language-models-for-axillary-surgery-recommendation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/medicaid-expansion-and-timely-colorectal-cancer-treatment-initiation-among-young-adults-in-virginia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/automated-detection-of-tertiary-lymphoid-structures-tls-on-whole-slide-pathology-images-using-an-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oral-fluoropyrimidines-as-alternatives-to-intravenous-5-fluorouracil-in-combination-with-immune-chec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-gastrointestinal-gi-immune-related-adverse-events-iraes-real-world-experience 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-emergent-thyroid-disorders-and-outcomes-of-first-line-pembrolizumab-plus-chemotherapy-in-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-time-to-treatment-initiation-in-mcl-a-seer-analysis-from-2000-2022 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nivolumab-and-ipilimumab-as-second-or-later-line-therapy-in-hepatocellular-carcinoma-a-retrospectiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-baseline-protein-energy-malnutrition-with-mortality-and-healthcare-utilization-in-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-adjuvant-chemoradiotherapy-vs-tegafurgimeraciloteracil-monotherapy-vs-ob 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-screening-in-the-transgender-population-examining-the-specificities-of-cancer-risk-from-a-he 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-evolution-of-her2-targeted-clinical-trials-across-solid-tumors-shifts-in-tumor-representatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-recurrence-and-outcome-determinants-in-nf1-associated-malignant-peripheral-nerve-sheath-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-first-in-human-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-prelimin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pharmacokinetics-and-pharmacodynamics-evaluation-in-phase-i-trial-of-apx-343a-selective-nox-inhibit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nrg-gi008-colon-adjuvant-chemotherapy-based-on-evaluation-of-residual-disease-circulate-north-amer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-open-label-multicenter-study-of-dptx3186-to-evaluate-safety-tolerability-and-pharmacokinetics 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-patterns-of-hyperlipidemia-and-cardiometabolic-toxicity-in-patients-with-alk-fusion-posi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/partial-breast-irradiation-followed-by-neoadjuvant-immunochemotherapy-in-early-tnbc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/time-dependent-recurrence-risk-stratification-after-neoadjuvant-chemotherapy-for-risk-adapted-survei 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-pharmacokinetics-and-neutropenia-related-pharmacodynamics-of-bal0891-in-patients-with-solid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-clinically-applicable-toolkit-for-cervical-gastric-type-adenocarcinoma-diagnostic-model-predicti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-locoregional-recurrence-lrr-in-hormone-receptor-hrher2-breast-cancer-bc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distinctive-profile-of-antiproliferative-activity-and-interaction-with-doxorubicin-of-a-new-indole-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-baseline-circulating-emdscs-in-patients-with-advanced-non-small-cell-lung-cancer-treat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-patients-with-pi3k-pathway-alterations-by-treatment-type-the-md-anderson-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-and-clinical-characteristics-of-patients-with-non-small-cell-lung-cancer-nsclc-harboring 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-systematic-review-and-meta-analysis-on-safety-and-efficacy-of-lu-177-psma-617-and-standardized-tre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hrs-5041-an-androgen-receptor-degrader-in-metastatic-castration-resistant-prostate-cancer-a-phase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-large-scale-multi-target-deep-learning-model-for-virtual-genomic-and-molecular-risk-profiling-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/timing-of-chemotherapy-in-breast-cancer-a-meta-analytic-evaluation-of-neoadjuvant-versus-adjuvant-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concordance-of-liquid-biopsy-and-tissue-cgp-for-identification-of-guideline-recommended-actionable-v 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radium-223-without-androgen-deprivation-therapy-adt-in-patients-pts-with-biochemically-recurrent 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trended-real-world-analysis-of-drug-treated-mcrpc-assessment-of-a-diagnostic-and-co-management-gap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-hypofractionated-radiotherapy-plus-gm-csf-on-antitumor-activity-with-pd-1pd-l1-inhibitors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-intrathecal-chemotherapy-in-iegfri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncologic-safety-and-patient-reported-outcomes-of-sentinel-lymph-node-biopsy-omission-in-early-breas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tissue-free-minimal-residual-disease-evaluation-and-clinical-utility-in-early-breast-cancer-a-real 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-cancer-survivorship-program-assessing-and-addressing-patients-needs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/digital-twin-models-for-counterfactual-prediction-in-nsclc-a-validation-study-using-clinical-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-from-a-pilot-trial-of-neoadjuvant-durvalumb-in-combination-with-tremelimuab-for-cisp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multicenter-clinical-study-of-sup18sup-falf-her2-bch 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burden-and-temporal-trends-of-pediatric-central-nervous-system-tumors-in-kenya-a-15-year-analysis-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gzmk-t-cells-in-glioblastoma-and-an-activated-non-exhausted-phenotype 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metabotyping-using-early-body-weight-velocity-in-lung-cancer-patients-treated-with-pembrolizumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-atm-as-a-prognostic-biomarker-in-non-small-cell-lung-cancer-a-systematic-review-and-meta-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lung-cancer-screening-in-septuagenarians-do-survival-benefits-persist-with-advancing-age 2026-08-24 monthly 0.7 https://rjrindex.com/articles/paxg-versus-mfolfirinox-as-first-line-therapy-for-unresectable-locally-advanced-or-metastatic-panc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/depletion-of-t-regulatory-cells-by-denileukin-diftitox-cxdl-e7777-in-combination-with-pembrolizuma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-responses-to-ugn-102-across-eortc-recurrence-score-groups-in-patients-with-recurrent-low-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-preliminary-efficacy-of-oh2-combined-with-bs006-sequential-intratumoral-injection-in-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/paired-urine-and-plasma-ctdna-profiling-to-enable-longitudinal-molecular-monitoring-during-her2-adc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/emergence-of-single-week-adjuvant-breast-radiation-therapy-for-early-stage-breast-cancer-in-the-unit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-systemic-therapy-sequencing-after-earlier-generation-egfr-tki-failure-in-nscl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biomarker-defined-outcomes-in-metastatic-clear-cell-renal-cell-carcinoma-mccrcc-receiving-first-li 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-overview-of-mortality-for-malignant-neoplasm-of-the-brain-and-cerebrovascular-diseases 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-quantum-scalpel-unveiling-new-dimensions-in-cancer-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-patterns-of-overtreatment-in-low-risk-and-undertreatment-in-high-risk-prostate-cancer-and-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-transportation-insecurity-among-cancer-patients-in-urban-cancer-clinics-in-ontario-canada 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adapt-t-dxd-multi-institutional-real-world-study-of-dose-adapted-trastuzumab-deruxtecan-in-her2-pos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-pathology-based-triage-for-the-21-gene-recurrence-score-a-meta-analysis-and-qualitati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/weekend-admission-and-early-in-hospital-mortality-among-patients-with-hematologic-malignancies-admit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlates-of-patient-enrollment-in-a-population-based-randomized-controlled-trial-of-cascade-geneti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genetic-signatures-of-cns-relapse-in-dlbcl-patients-profiled-with-next-generation-sequencing-ngs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/response-to-neoadjuvant-chemoimmunotherapy-in-egfr-or-alk-mutated-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-real-world-comparison-of-treatment-and-survival-outcomes-with-zanubrutinib-zanu-and-acalabrutini 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transdermal-drug-delivery-to-the-normal-and-the-radiated-breast-determinants-of-individual-variatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-and-subgroup-efficacy-analysis-of-ga-68-ngul-and-lu-177-dgul-pocuvotide-satetraxe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-of-glucagon-like-peptide-1-receptor-agonists-in-patients-with-breast-cancer-a-real-world-mul 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-and-subsequent-treatment-utilization-following-anti-b-cell-maturation-antigen-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trabectedin-with-concomitant-radiotherapy-in-resectable-retroperitoneal-l-sarcoma-a-multicenter-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-assisted-preoperative-communication-in-prostate-cancer-a-prospective-single-blinded-randomized 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-trial-of-asciminib-for-newly-diagnosed-chronic-myeloid-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-modern-systemic-and-multimodality-treatments-on-post-relapse-survival-in-retroperitoneal-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-effect-of-obecabtagene-autoleucel-obe-cel-on-adult-patients-pts-with-relapsedrefractory-b-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-induction-strategies-in-acute-myeloid-leukemia-10-year-real-world-experience-with-73-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-experience-with-neoadjuvant-chemoimmunotherapy-in-resectable-nsclc-a-single-academic-ins 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-determinants-of-metastatic-burden-and-survival-in-metastatic-urothelial-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/serial-ctdna-genomic-profiling-integrated-with-a-networked-molecular-tumor-board-in-first-line-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-and-safety-of-central-nervous-system-tumor-patients-in-phase-1-trials-a-single-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/objective-response-rates-with-ori-c101-an-armored-gpc3-directed-car-t-in-heavily-pretreated-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-of-peripheral-blood-immune-analysis-in-patients-receiving-immune-checkpoint-inhibitor-therap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/scaling-digital-patient-navigation-to-improve-access-to-multidisciplinary-melanoma-care 2026-08-24 monthly 0.7 https://rjrindex.com/articles/capivasertib-plus-fulvestrant-in-chinese-patients-with-hrher2-advanced-breast-cancer-interim-ana 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-efficacy-and-safety-of-first-line-anlotinib-plus-carboplatinpaclitaxel-induction-therap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/proglumide-gemcitabine-gem-and-nab-paclitaxel-nab-p-in-patients-pts-with-pancreatic-ductal-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-financial-and-credit-status-of-participants-enrolled-in-swog-s1912cd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/virtual-multiplex-immunofluorescence-characterization-of-spatial-immune-architectures-and-tertiary-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/large-cell-carcinoma-with-rhabdoid-phenotype-demographics-treatment-and-survival-in-the-ncdb 2026-08-24 monthly 0.7 https://rjrindex.com/articles/whole-genome-sequencing-based-ultra-sensitive-ctdna-molecular-residual-disease-assessment-in-resecta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-ischemic-heart-disease-mortality-among-lymphoma-patients-in-the-united-states-19 2026-08-24 monthly 0.7 https://rjrindex.com/articles/brentuximab-vedotin-plus-cyclophosphamide-doxorubicin-etoposide-and-prednisone-chepa-in-newly-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disitamab-vedotin-rc48-tislelizumab-and-s-1-as-first-line-therapy-for-her2-overexpressing-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/when-does-time-become-a-burden-evaluating-the-association-between-time-spent-on-cancer-care-and-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-on-overall-survival-after-adjusting-for-treatment-crossover-in-first-line-metastatic-nsclc-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sequencing-of-fallopian-tube-p53-signature-found-concurrently-with-p53-mutant-uterine-cancers-and-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-personalized-neoantigen-vaccine-to-reprogram-the-immune-landscape-of-glioblastoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-after-intravenous-iron-use-in-patients-with-cancer-and-iron-deficiency-a-propensit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-knowledge-distilled-efficientnet-to-enable-rapid-scalable-glioma-diagnosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-postsurgical-circulating-tumor-dna-ctdna-dynamics-on-eligibility-of-colorectal-cancer-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/progression-free-survival-as-a-surrogate-endpoint-for-overall-survival-in-metastatic-triple-negative 2026-08-24 monthly 0.7 https://rjrindex.com/articles/azenosertib-plus-paclitaxel-for-platinum-resistant-ovarian-cancer-results-from-a-phase-1b-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-immune-related-pathologic-response-score-as-a-predictor-of-survival-after-immune-checkpoint-inhib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-and-biomarker-landscape-of-mtap-deficiency-in-gastrointestinal-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-heat-shock-protein-90-alpha-hsp90a-as-a-biomarker-for-cancer-cachexia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-automated-ehr-integrated-intervention-system-for-patient-reported-insomnia-symptoms 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-changes-in-patient-reported-quality-of-life-qol-and-hope-among-early-phase-cancer-cli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fire-4-aio-krk-0114-efficacy-of-third-line-rechallenge-with-cetuximab-versus-investigators-choic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-primary-cardioprotection-with-perindopril-bisoprolol-and-trimetazidine-in-high-risk-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-cldn18cldn182-ihc-assays-43-14a-vs-epr19202-and-the-correlation-with-clinical-effi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-artificial-intelligence-to-evaluate-outcomes-and-disparities-in-young-onset-breast-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-classification-of-neuroendocrine-carcinoma-of-the-bladder 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-circulating-tumor-dna-ctdna-profiling-from-patients-pts-treated-with-zanidatamab-che 2026-08-24 monthly 0.7 https://rjrindex.com/articles/refining-breast-cancer-risk-stratification-for-selection-of-women-at-intermediate-to-high-risk-for-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burnout-among-caregivers-of-hospitalized-medical-oncology-patients-a-cross-sectional-survey-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/standardized-exam-style-benchmarking-of-large-language-models-in-breast-cancer-clinical-decision-mak 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-oral-serds-including-giredestrant-on-survival-in-hr-her2-metastatic-breast-cancer-a-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reproductive-and-pregnancy-related-outcomes-among-adolescent-and-young-adult-female-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-detection-of-multiple-myeloma-and-mgus-progression-risk-using-artificial-intelligence-and-rout 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trilaciclib-for-myeloprotection-in-adjuvant-and-first-line-chemotherapy-for-advanced-gastricgastroe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phlebotomy-adherence-and-hematocrit-control-in-patients-with-polycythemia-vera-in-the-united-state 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bl0020-a-novel-tumor-microenvironment-tme-targeting-nano-mediated-polypeptide-drug-conjugate-nmp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adverse-events-and-their-management-in-patients-with-tenosynovial-giant-cell-tumor-tgct-treated-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systemic-cytokine-dynamics-during-neoadjuvant-chemotherapy-versus-endocrine-therapy-and-cdk46-inhib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-pharmacokinetics-pk-of-lurbinectedin-lurbi-in-pediatric-patients-pts-with-relapsed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-burden-and-outcomes-colon-cancer-survival-across-the-us-safety-net-spectrum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-comparing-the-use-of-glp-1-receptor-agonists-in-patients-with-endometrial-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-whole-exome-and-whole-genome-sequencing-tumor-informed-circulating-tumor-dna-mrd-assay 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pemigatinib-for-untreated-unresectablemetastatic-cholangiocarcinoma-mcca-with-fibroblast-growth-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fecal-microbiota-transplantation-to-reverse-resistance-to-tki-plus-pd-1-inhibitors-in-unresectable-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-and-prognostic-value-of-mri-radiomics-in-patients-with-hormone-receptor-positive-her2-ne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidental-breast-findings-identified-on-non-breast-imaging-a-multi-facility-real-world-analysis-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-schwann-cells-with-immune-cold-tumor-microenvironment-in-triple-negative-breast-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systematic-modeling-of-tumor-microenvironment-mediated-nk-cell-dysfunction-in-pancreatic-cancer-to-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clerad-probe-dosimetric-analysis-of-i-124-pet-guided-remnant-radioiodine-ablation-in-differentiated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differential-gene-detection-and-turnaround-time-between-tissue-and-guardant360-liquid-biopsy-next-ge 2026-08-24 monthly 0.7 https://rjrindex.com/articles/informing-optimal-duration-of-adjuvant-chemotherapy-act-in-resected-stage-i-iv-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dose-dependent-effect-of-dinutuximab-ir700-photoimmunotherapy-on-gd2-expressing-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-study-of-ct-01-a-dual-molecular-glue-degrader-of-gspt1-and-nek7-as-monotherapy-and-in-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/apobec-mutational-signatures-to-predict-immune-checkpoint-inhibitor-benefit-in-tmb-low-metastatic-ns 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-cancer-expanded-multigene-panel-testing-in-hereditary-cancer-patients-from-the-baja-californ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-testing-first-line-treatment-patterns-and-survival-in-metastatic-non-small-cell-lung-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-survival-longitudinal-prognostication-in-glioblastoma-using-conditional-survival-a-populatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-neutrophil-percentage-to-albumin-ratio-with-progression-free-survival-and-overall-sur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-outcomes-pros-and-health-related-quality-of-life-hrqol-with-taletrectinib-in-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/guideline-adherence-in-action-baseline-neuroimaging-rates-for-nsclc-a-northern-ireland-north-west-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/obesity-associated-genomic-heterogeneity-in-breast-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-patients-with-cell-cycle-alterations-by-treatment-type-the-md-anderson-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/testosterone-suppression-safety-and-adherence-with-relugolix-in-patients-with-metastatic-prostate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-dostarlimab-monotherapy-as-first-line-treatment-in-programmed-cell-death-liga 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-from-ocean-ii-a-phase-ii-study-of-encorafenib-binimetinib-combination-in-chinese-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/refined-temporal-to-frontal-horn-shunting-for-trapped-temporal-horn-syndrome-long-term-outcomes-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiovascular-comorbidity-burden-and-in-hospital-outcomes-in-patients-with-lung-cancer-a-retrospec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plasma-tmb-ptmb-and-circulating-tumor-fraction-ctf-dynamics-as-biomarkers-of-benefit-from-the-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-hyperthermic-intraperitoneal-chemotherapy-hipec-with-cytoreduction-in-peritoneal-metas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-characteristics-homologous-recombination-repair-mutation-hrrm-testing-treatment-patte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/iconic-improving-outcomes-through-collaboration-in-osteosarcoma-insights-from-a-national-prospect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-potential-of-prostest-for-predicting-outcome-in-adt-treated-black-south-african-prostate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-dose-adjusted-etoposide-prednisone-vincristine-cyclophosphamide-and-doxorubici 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dyadic-exercise-intervention-for-lgbtq-cancer-survivors-associations-with-health-related-quality-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/same-daynext-day-cancer-care-program-an-early-access-program-for-patients-with-aggressive-malignan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/blood-derived-small-extracellular-vesicle-based-liquid-biopsy-for-repeatable-genomic-and-transcripto 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-ai-augmented-analysis-of-quantitative-circulating-tumor-dna-ctdna-burden 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-cell-characterization-of-renal-cell-carcinoma-brain-metastasis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anti-pd-1-pd-1-monotherapy-versus-combination-with-anti-ctla-4-for-metastatic-uveal-melanoma-mum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-early-on-treatment-cytokine-dynamics-following-induction-chemo-immunotherapy-with-pro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-translational-study-of-p38-inhibitor-pexmetinib-plus-nivolumab-following-anti-pd-1l1-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/proactive-response-initiative-for-symptom-management-prism-a-multi-institutional-symptom-monitori 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-single-center-retrospective-analysis-of-antibody-drug-conjugate-utilization-and-associated-toxicit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/post-treatment-ctdna-monitoring-using-a-tumor-informed-whole-genome-sequencing-based-assay-in-homolo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-first-line-treatment-of-cllsll-with-the-all-oral-combination-of-sonrotoclax-sonro-and-z 2026-08-24 monthly 0.7 https://rjrindex.com/articles/coverage-of-subcutaneous-versus-intravenous-oncology-therapies-by-us-commercial-health-plans 2026-08-24 monthly 0.7 https://rjrindex.com/articles/whole-genome-sequencing-based-ctdna-testing-for-post-surgical-monitoring-and-early-detection-of-recu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-molecular-profiling-in-advanced-non-small-cell-lung-cancer-nsclc-measurable-surviva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-and-adjuvant-pembrolizumab-plus-chemotherapy-for-locally-advanced-gastric-or-gastroesoph 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-deep-learning-model-for-intraoperative-diagnosis-of-lung-adenocarcinoma-using-frozen-section-whole 2026-08-24 monthly 0.7 https://rjrindex.com/articles/recurrence-patterns-and-site-level-survival-in-the-previous-phase-iii-study-of-il13-pe38qqr-implica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/knowledge-distillation-for-glioma-diagnosis-resnet-based-deep-learning-for-who-grade-stratification 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-determinants-of-radiation-necrosis-in-diffuse-glioma-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-immunotherapy-era-on-survival-in-stage-iv-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-intravenous-ipi201-in-combination-with-anti-pd-1-therapy-in-a-colorectal-cancer-mouse 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-characteristics-of-nsclc-first-line-immunotherapy-super-responders-in-three-european-lung-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/time-to-treatment-initiation-and-clinical-toxicity-and-supportive-care-outcomes-in-multiple-myelom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-and-longitudinal-capture-of-routine-patient-reported-outcomes-in-non-small-cell-lung 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-patients-with-glioblastoma-multiforme-gbm-with-lymphopenia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leader-member-exchange-lmx-and-workforce-outcomes-in-radiation-oncology-a-preliminary-generationa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-model-for-lung-cancer-risk-stratification-using-routine-complete-blood-count-exams 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-deoxyribonucleic-acid-dna-and-treatment-outcomes-of-gastroesophageal-cancer-a-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrative-genomic-profiling-of-indian-brain-tumors-prognostic-markers-and-actionable-therapeutic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/resnets-in-the-diagnosis-of-gliomas-knowledge-distillation-from-resnet101-to-resnet18-for-accurate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biologic-and-clinical-implications-of-hpv-genome-state-variation-in-oropharyngeal-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/extended-monitoring-and-biomarker-analysis-in-metastatic-melanoma-patients-treated-with-til-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-prediction-for-progression-free-survival-pfs-and-overall-survival-os-by-genomic-instabi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-career-focused-training-program-leader-perspectives-on-professional-development-pathways 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trastuzumab-deruxtecan-for-the-management-of-leptomeningeal-metastases-from-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cross-platform-concordance-between-tumor-informed-and-tumor-naive-ctdna-mrd-assays-in-early-stage-ns 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-mortality-and-disability-burden-of-young-onset-non-colorectal-gastrointestinal-cancers-1990 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-profiling-of-diffuse-intrinsic-pontine-glioma-in-aacr-project-genie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-impact-of-first-line-platinum-plus-two-day-etoposide-combined-with-immunotherapy-in-extensi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neurological-adverse-events-related-to-immune-checkpoint-inhibitors-in-cancer-treatment-a-systemati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-spatial-atlas-of-adc-targets-in-immunotherapy-treated-nsclc-to-link-compartment-specific 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effectiveness-of-car-t-cells-engineered-with-tgf-vril-9r-domain-swapped-chimeric-receptor-and-membr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/frequent-monitoring-of-nsclc-immunotherapy-using-an-mdetect-liquid-biopsy-to-identify-therapy-respon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-multi-center-pharmacodynamic-study-of-the-fatty-acid-synthase-fasn-inhibitor-tvb-2640-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/automatic-pharmacogenomic-testing-provided-on-liquid-biopsy-access-prevalence-and-integration-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neutrophil-counts-as-a-prognostic-biomarker-following-breast-cancer-surgery-insights-from-a-mayo-cl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-failure-and-outcomes-in-triple-negative-compared-to-estrogen-receptor-positive-breast-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-imtapi-copy-number-alteration-cna-in-nsc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-benefits-of-early-phase-clinical-trials-for-rare-malignancies-asian-single-center-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-triage-forward-outpatient-diagnostic-pathway-for-cancer-evaluation-early-experiences-from-a-suspi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-environmental-factors-and-social-determinants-of-health-on-molecular-alterations-in-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-safety-of-elranatamab-in-low-weight-patients-findings-from-the-summit-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinician-readiness-and-ethical-thresholds-for-agentic-ai-autonomy-in-oncology-care-a-multi-special 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-fine-tuned-small-language-models-slms-vs-large-language-models-llms-in-modeled-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rapid-ai-assisted-intraoperative-diagnosis-for-biliary-tract-adenocarcinoma-using-femtosecond-laser 2026-08-24 monthly 0.7 https://rjrindex.com/articles/building-a-real-time-cancer-data-mart-cdm-for-an-integrated-health-system-leveraging-traditional 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-convolution-vision-transformer-based-modeling-for-histopathological-classification-of-colore 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-12-month-overall-survival-from-response-rate-and-6-month-progression-free-survival-in-onc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-analysis-of-aggressive-disease-and-treatment-response-in-recurrentmetastatic-head-and-nec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/can-functional-tumor-profiling-lead-to-superior-care-within-standard-of-care-a-meta-analysis-of-ra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/childcare-provision-during-breast-cancer-radiation-therapy-piloting-of-the-waiting-room-watchers-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-cancer-screening-uptake-and-barriers-among-women-in-hue-vietnam-a-cross-sectional-survey 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-deviations-from-guideline-concordant-care-in-triple-negative-breast-cancer-a-patient-reported 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-evaluation-of-targeted-rna-sequencing-and-rna-exome-sequencing-for-fusion-detection-in-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-the-fertility-divide-disparities-across-counseling-referral-and-utilization-of-fertility 2026-08-24 monthly 0.7 https://rjrindex.com/articles/building-a-patient-driven-integrated-research-infrastructure-to-accelerate-therapeutic-advances-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analytical-characterization-of-the-next-generation-her2-cal27-immunohistochemistry-assay-a-compar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-resource-impact-and-disparities-in-low-value-care-during-terminal-hospitalizations-for-lu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pre-treatment-circulating-tumour-dna-ctdna-to-predict-survival-and-aid-decision-making-in-head-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perspectives-of-oncology-professionals-on-cancer-care-for-displaced-populations-in-africa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/postpartum-associated-breast-cancer-patient-outcomes-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-trends-colorectal-carcinoma-associated-with-tobacco-use-as-a-cause-of-death-in-the-united 2026-08-24 monthly 0.7 https://rjrindex.com/articles/endometrial-cancer-risk-management-in-patients-with-lynch-syndrome-at-a-tertiary-community-cancer-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-characteristics-and-real-world-utilization-of-darolutamide-in-advanced-prostate-cancer-among 2026-08-24 monthly 0.7 https://rjrindex.com/articles/postoperative-circulating-tumor-dna-for-recurrence-risk-assessment-and-adjuvant-therapy-decision-mak 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-process-mapping-to-improve-clinical-care-for-patients-receiving-cancer-treatment-in-resource-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-pre-diagnostic-upper-endoscopy-and-metastatic-gastric-cancer-at-diagnosis-among 2026-08-24 monthly 0.7 https://rjrindex.com/articles/insurance-related-disparities-in-emergency-department-presentation-among-hospitalized-colorectal-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-enabled-analysis-of-prognostic-pi3k-pathway-alterations-in-african-american 2026-08-24 monthly 0.7 https://rjrindex.com/articles/histology-dependent-survival-and-treatment-benefit-in-primary-tracheal-cancer-a-population-based-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-trends-in-the-evolving-use-of-first-line-therapy-in-metastatic-castration-sensitive-prost 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-early-onset-colorectal-cancer-a-20-year-epidemiological-study-at-a-referral-center-in-nor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-with-immune-checkpoint-inhibitors-in-patients-with-pre-existing-autoimmune-disease 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-feasibility-and-tolerability-of-pedmark-for-otoprotection-in-young-adults-receiving-cispl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-demographic-characteristics-in-ameloblastoma-patients-a-single-center-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/feasibility-assessment-of-a-global-anonymized-human-in-the-loop-ai-decision-support-platform-for-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/screen-failures-among-patients-who-consented-for-early-phase-cancer-clinical-trials-epcts 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tcm-based-syndrome-stratification-and-biological-profiling-of-cancer-related-fatigue-a-cross-sectio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integration-of-a-diabetes-practitioner-in-breast-cancer-care-and-its-impact-on-glucose-management 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-effectiveness-of-adjuvant-tace-versus-haic-after-curative-resection-for-high-risk-bclc-0 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-as-a-determinant-of-systemic-therapy-initiation-in-advanced-colorectal-cancer-experience-from-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-with-adjuvant-chemotherapy-in-patients-with-early-stage-biliary-tract-cancers-an-ncdb-anal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/making-telehealth-delivery-of-cancer-care-at-home-effective-and-safe-a-pragmatic-cluster-randomized 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-squalene-epoxidase-association-with-cholesterol-dependent-akt-activation-and-prognosis-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sequencing-antibody-based-and-car-t-therapies-in-relapsedrefractory-follicular-lymphoma-an-anchore 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trust-ethics-and-patient-engagement-in-clinical-research-findings-from-the-lacog-1123-astral-surv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interim-analysis-of-efficacy-and-safety-of-adjuvant-donafenib-plus-transarterial-chemoembolization-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gliofocus-a-global-open-label-randomized-phase-3-study-comparing-niraparib-with-temozolomide-in-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/polaris-polymetastatic-lesion-ablative-radiotherapy-with-immunotherapy-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pre-operative-chemotherapy-versus-surgery-first-with-peri-operative-interventions-in-early-triple-ne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lisocabtagene-maraleucel-liso-cel-as-first-line-1l-therapy-for-transplant-ineligible-patients-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inequality-of-access-to-breast-reconstruction-in-brazil-an-ecological-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-randomized-trial-of-tislelizumab-plus-gemcitabinecapecitabine-gx-versus-tislelizumab-pl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/economic-burden-of-non-approved-alternative-therapies-among-patients-with-stage-iv-cancer-a-prospec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quintessential-2-a-phase-3-study-of-arlocabtagene-autoleucel-versus-standard-of-care-in-adult-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-non-comparative-multicenter-phase-ii-trial-of-neoadjuvant-becotatug-vedotin-alone-or 2026-08-24 monthly 0.7 https://rjrindex.com/articles/durvalumab-and-oleclumab-in-resectable-pancreatic-ductal-adenocarcinoma-a-window-of-opportunity-tri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-in-hospital-outcomes-among-patients-with-lung-cancer-receiving-immune-checkpoi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/falls-among-older-adults-with-cancer-a-nationwide-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/construction-and-clinical-application-of-a-bundled-nursing-care-program-for-picc-management-in-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-and-disparities-in-liver-cancer-incidence-in-the-united-states-1999-2022-a-nationw 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1b2-trial-of-melphalan-percutaneous-hepatic-perfusion-php-therapy-and-nivolumabrelatlimab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-absk061-selective-fgfr23-inhibitor-combined-with-absk043-oral-pd-l1-inhibitor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reducing-oncology-transportation-burden-with-decentralized-treatment-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-microplastics-on-the-colorectal-tumor-immune-microenvironment-and-immunotherapy-resistanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-angiogenic-fibrotic-and-immunosuppressive-tumor-microenvironment-with-immunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-toxicity-of-the-antitumor-agent-spesn38-8 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-mortality-and-disparities-in-small-intestine-neoplasms-among-us-adults-aged-65-years-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-mortality-related-to-malignant-genital-neoplasms-in-the-united-states-199 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-chemotherapy-after-parp-inhibitor-progression-in-ovarian-cancer-a-large-real-world-coho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distinguishing-hemoglobin-nadir-from-clinically-significant-anemia-events-during-curative-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sequencing-trastuzumab-deruxtecan-and-sacituzumab-govitecan-in-metastatic-breast-cancer-a-systemati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plasma-levels-of-mitochondrial-gene-copy-number-and-microrna-transcripts-as-effective-minimally-inva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-real-world-safety-of-nivolumab-versus-pembrolizumab-in-malignant-melanoma-a-propensity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prior-authorization-utilization-administrative-burden-and-implications-for-timely-care 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-line-therapeutic-strategies-following-resistance-to-egfr-tkis-in-advanced-egfr-mutant-nsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-gvax-pancreas-vaccine-with-crs-207-in-pretreated-metastatic-pancreatic-adenoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inpatient-chemotherapy-in-small-cell-lung-cancer-as-a-high-risk-care-delivery-phenotype-national-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-approach-to-identify-country-specific-drivers-of-global-cancer-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-lessons-from-the-implementation-of-a-pan-african-clinico-genomic-cancer-platform-the-african 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-of-the-randomized-phase-2-dose-optimization-study-of-alveltamig-zg006-a-trispecif 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alcohol-related-hospitalizations-among-patients-with-cancer-in-the-united-states-trends-and-associa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/race-associated-clinicogenomic-predictors-in-non-small-cell-lung-cancer-treated-with-immune-checkpoi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-of-teratoma-components-in-germ-cell-tumor-patients-undergoing-high-dose-chem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-skeletal-muscle-index-as-an-independent-prognostic-factor-in-locally-advanced-head-and-neck 2026-08-24 monthly 0.7 https://rjrindex.com/articles/covid-19-mrna-vaccination-and-risk-of-immune-related-adverse-events-in-ici-treated-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-pregnancy-associated-cancer-mortality-in-the-united-states-a-national-analysis-2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-car-t-clinical-trial-availability-and-accessibility-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/how-long-is-long-enough-outcomes-with-finite-duration-bispecific-antibody-therapy-in-multiple-myelo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pre-transplant-mrd-negativity-and-tp53-mutation-status-determine-survival-after-car-t-therapy-bridge 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-of-young-patients-with-non-small-cell-lung-cancer-in-latin-america-a-real-world-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/olanzapine-for-chemotherapy-related-anorexia-impact-on-body-composition 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-prior-treatment-setting-on-the-efficacy-of-rucaparib-vs-physicians-choice-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-study-of-225acac-psma-xt-a-novel-alpha-particle-emitting-radioligand-therapy-in-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-personalized-ctdna-into-clinical-surveillance-of-soft-tissue-sarcoma-performance-timin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/recurrence-risk-prediction-using-a-large-multi-site-observational-dataset-of-patients-with-early-br 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pharmacokinetic-variability-with-pembrolizumab-dosage-switching-and-its-impact-on-immune-related-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-payload-resistant-human-ovarian-cancer-cell-lines-to-better-understand-antibody-drug 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ultra-sensitive-circulating-tumor-dna-ctdna-detection-as-predictor-of-survival-outcomes-in-endomet 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-facility-type-and-metastatic-burden-with-survival-in-gastric-adenocarcinoma-a-nation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancertrialsbr-an-open-access-collaborative-platform-to-improve-visibility-and-access-to-cancer-cl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/paclitaxel-plus-bevacizumab-with-or-without-atezolizumab-for-hormone-receptor-positiveher2-negative 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-outcomes-of-germline-and-sporadic-nf1-associated-gastrointestinal-strom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-meilian-fuxin-liquid-for-radiation-induced-oral-mucositis-in-head-and-neck-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-multicenter-study-of-nasox-regimen-as-adjuvant-chemotherapy-for-patients-with-resected-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-cell-analysis-of-plasma-cell-centered-inflammatory-immunosuppressive-niches-and-response-to-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/precision-histopathologic-classification-of-epithelial-ovarian-cancer-subtypes-using-a-computational 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-neoadjuvant-spatially-fractionated-stereotactic-body-radiotherapy-on-antitumor-immunity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ibiia-study-of-bat8010bat1006-an-anti-her2-monoclonal-antibody-exatecan-conjugate-combine-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathologic-features-of-south-african-colorectal-cancer-patients-by-hiv-status-in-a-retrospect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-tislelizumab-as-neoadjuvant-therapy-combined-with-mrd-monitoring-in-locally-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-and-responsiveness-of-standard-tyrosine-kinase-inhibitor-dose-versus-dose-de-escalation-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-imaging-as-a-tool-to-predict-patient-outcomes-in-advanced-her2-low-breast-cancer-on-trastu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tegavivint-a-downstream-wntv-catenin-inhibitor-dose-finding-results-from-a-phase-12-trial-in-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prediction-of-anthracycline-related-cardiomyopathy-in-long-term-childhood-cancer-survivors-the-powe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/refining-clinical-trial-eligibility-for-minimal-residual-disease-in-patients-with-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multiplexed-immunohistochemistry-mihc-analysis-and-clinical-outcomes-of-nelmastobart-in-combinatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-cell-intrinsic-programs-of-metabolic-adaptation-and-immune-evasion-in-colorectal-cancer-liver 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tisagenlecleucel-tisa-cel-in-pediatric-and-young-adult-patients-with-high-risk-hr-b-cell-acute-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-overlapping-burden-of-atrial-fibrillation-and-lung-cancer-insights-from-us-mortality-data-fro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/doubling-cascade-testing-uptake-for-hereditary-cancer-syndromes-results-from-a-cluster-randomized-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-pragmatic-hybrid-observational-study-evaluating-the-effectiveness-of-trastuzumab-deruxtecan-t-dx 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-pilot-study-of-autologous-tumor-infiltrating-lymphocytes-ln-145-in-adult-patients-with-undiffere 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-adnexal-features-and-histological-response-to-intralesional-sp-002-in-nodular-basal-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-patterns-of-dose-reduction-and-early-discontinuation-of-abemaciclib-for-early-stage-horm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-study-of-sup225sup-acac-etn029-a-dll3-targe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ctdna-analysis-in-participants-with-renal-cell-carcinoma-treated-with-adjuvant-pembrolizumab-or-plac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-patterns-of-pd-l1-expression-biomarker-testing-and-immunotherapy-utilization-across-lun 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-nivolumab-combined-with-brentuximab-vedotin-in-patients-with-relapsed-and-ref 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-predictors-of-delayed-hematologic-engraftment-after-autologous-stem-cell-transplantati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-syngeneic-immunocompetent-mouse-model-of-gbc-to-reveal-cxcl5-mediated-early-tumor-progressio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/failure-to-rescue-following-acute-hepatic-decompensation-in-hospitalized-patients-with-hepatocellula 2026-08-24 monthly 0.7 https://rjrindex.com/articles/donafenib-plus-sintilimab-combined-with-tace-or-haic-for-unresectable-hepatocellular-carcinoma-a-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-affordability-of-the-asco-annual-meeting-a-longitudinal-analysis-over-5-years 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-trial-of-lisocabtagene-maraleucel-for-minimal-residual-disease-in-patients-with-large-b-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncofertility-counseling-practices-in-aya-patients-diagnosed-with-stage-i-iii-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fetal-like-epithelial-niches-at-the-invasive-margin-to-inform-prognosis-in-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-neoadjuvant-tchp-with-primary-empegfilgrastim-e-prophylaxis-in-her2-positive-early-bre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trajectories-of-circulating-epithelial-tumor-cells-for-early-prostate-cancer-detection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-the-geographic-redistribution-of-mmat-3-policy-on-regional-and-socioeconomic-disparities-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/afatinib-versus-chemotherapy-in-advanced-nsclc-with-uncommon-iegfri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-and-safety-of-first-line-combination-therapies-with-third-generation-egfr-tkis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pmh-001-a-first-in-human-phase-i-study-of-the-novel-microtubule-disruptor-cci-001-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/determinants-of-trial-completion-termination-and-efficacy-in-solid-tumor-immunotherapy-mapping-io 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-the-role-of-large-language-models-in-cancer-mortality-prediction-a-real-world-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-network-meta-analysis-of-efficacy-and-safety-of-neoadjuvant-anti-her2-treatments-in-her2-positive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metal-exposure-and-ki67-response-to-neoadjuvant-aromatase-inhibitor-therapy-in-estrogen-receptor-pos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-spatial-transcriptomics-single-nucleus-rna-sequencing-and-histopathology-to-reveal-immu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-caregiver-and-patient-burden-with-alk-positive-advanced-non-small-cell-lung-cancer-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-online-cme-on-addressing-clinical-decision-making-for-immunotherapy-in-advanced-squamo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sezanne-a-phase-2-randomized-open-label-multicenter-study-to-evaluate-the-optimal-dose-safety-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoirenie-a-phase-2-randomized-trial-of-intensified-neoadjuvant-therapy-for-melanoma-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-study-of-hwk-007-a-next-generation-protein-tyrosine-kinase-7-ptk7-targeted-antibody-dr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-open-label-single-arm-dose-finding-and-expansion-phase-1b2-study-to-evaluate-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-protocol-improvemf-a-phase-1b-trial-of-imetelstat-ime-ruxolitinib-rux-in-patients-pt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-covid-19-on-short-and-long-term-outcomes-in-patients-with-diffuse-large-b-cell-lymphoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-or-adjuvant-pd-1pd-l1-blockade-with-curative-intent-multimodality-therapy-for-locally 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-risk-assessment-using-the-mirai-breast-cancer-risk-prediction-model-a-preliminary-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-awareness-to-action-a-mixed-method-community-study-on-uptake-of-population-based-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-combined-transarterial-embolizationchemoembolization-and-hepatic-arterial-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-early-access-to-cancer-medicines-in-the-united-kingdom-following-incorporation-of-the-fd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-associated-with-time-to-breast-cancer-treatment-initiation-at-an-urban-safety-net-center 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stage-gap-and-projected-metastatic-surge-for-young-onset-colorectal-cancer-a-decade-long-call-to-ac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-burden-of-retinoblastoma-incidence-prevalence-and-mortality-in-the-united-states-1990 2026-08-24 monthly 0.7 https://rjrindex.com/articles/peg-timing-in-head-and-neck-cancer-is-there-a-sweet-spot-a-real-world-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-darovasertib-in-uveal-melanoma-patients-undergoing-primary-local-therapy-optimum-10-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-utility-of-ngs-in-patient-stratification-for-first-line-chemotherapy-in-locally-advancedad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-factors-driving-use-of-ret-inhibitor-pralsetinib-and-associated-real-world-outcomes-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-pregnancy-outcomes-following-temporary-interruption-of-adjuvant-endocrine-therapy-in-earl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-the-covid-19-pandemic-on-early-stage-breast-cancer-post-lumpectomy-breast-radiation-therap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-early-nlr-normalization-in-msi-h-mcrc-a-real-world-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/social-deprivation-index-sdi-as-a-predictor-of-racial-and-ethnic-disparity-in-a-large-real-world-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inequities-in-breast-cancer-mortality-with-contributing-cardiometabolic-disorders-among-us-women-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-of-anal-cancer-in-the-united-states-an-analysis-of-npcr-data-and-comparison-to-seer-1998 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-line-options-in-patients-with-braf-negative-advanced-melanoma-following-progression-on-anti-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-manual-to-ai-assisted-improving-infusion-scheduling-in-a-high-volume-cancer-center 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-assessment-of-the-impact-of-neighborhood-vulnerabilities-on-prostate-cancer-outcomes-in-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-subtype-and-survival-in-inflammatory-breast-cancer-a-contemporary-population-based-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-depression-and-associated-factors-among-patients-with-advanced-cancer-undergoing-compr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-experience-based-assessment-of-informed-consent-forms-written-by-generative-artificial-inte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-and-in-hospital-outcomes-of-intracoronary-imaging-during-percutaneous-coronary-inter 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-and-prognostic-value-of-plasma-d-dimer-levels-for-metastasis-and-survival-in-gastric-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-endoscopic-sleeve-en-bloc-resection-for-sinonasal-mucosal-melanoma-a-propensity-score-match 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-chemotherapy-in-metastatic-colorectal-cancer-with-liver-dysfunction-due-to-he 2026-08-24 monthly 0.7 https://rjrindex.com/articles/post-neoadjuvant-prognostic-nutritional-index-as-a-predictor-of-pathological-response-and-survival-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-pneumococcal-disease-in-patients-with-b-cell-malignancies-a-retrospective-cohort-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perceived-financial-barriers-and-delayed-hospital-care-for-breast-and-cervical-cancer-in-nigeria-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-and-caregiver-knowledge-and-understanding-of-acute-myeloid-leukemia-and-satisfaction-with-on 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-analysis-and-therapeutic-management-of-radiation-induced-sarcomas-of-the-head-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-mortality-from-unspecified-malignant-neoplasm-of-the-liver-among-us-adults-aged-45-year 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-adding-s-1-to-chemotherapy-regimens-in-advanced-gastric-cancer-a-meta-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/verification-of-clinical-benefit-following-fda-accelerated-approval-in-oncology-a-time-to-event-ana 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-feasibility-study-of-tumor-infiltrating-lymphocytes-til-in-patients-with-cutaneous-squamous-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glucagon-like-peptide-1-receptor-agonist-glp-1-ra-and-hematologic-cancer-risk-among-older-adults-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lenalidomide-plus-rituximab-for-relapsedrefractory-indolent-non-hodgkin-lymphoma-5-year-follow-up 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-first-in-human-phase-i-dose-escalation-and-dose-expansion-study-of-trophoblast-cell-surfac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/modular-car-t-cells-advancing-flexibility-safety-and-efficacy-in-solid-cancer-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ctdna-as-a-complement-to-gene-expression-based-site-prediction-to-guide-therapy-in-cancer-of-unknown 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-clinical-significance-of-itet2i-driven-clonal-hema 2026-08-24 monthly 0.7 https://rjrindex.com/articles/detection-of-adaptive-immune-receptor-cdr3s-in-tumor-proteomes-and-correlations-with-survival-probab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/topoisomerase-1-and-dna-damage-pharmacodynamic-responses-and-mechanism-of-trastuzumab-deruxtecan-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcome-of-neoadjuvant-immunotherapy-for-patients-with-resectable-stage-iiiiv-cutaneous-melanoma-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-telpegfilgrastim-in-the-prophylaxis-of-chemotherapy-induced-neutropenia-in-br 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-snhg11-as-a-prognostic-and-predictive-biomarker-for-anti-egfr-benefit-in-colorectal-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunotherapy-for-uncommon-iegfri-mutations-in-lung-ade 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-tumor-immune-microenvironment-and-real-world-efficacy-of-first-line-immunotherap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/iher2i-mutations-in-advanced-nsclc-prevalence-mutational-context-and-cli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evidence-on-changes-in-uptake-sepsis-and-costs-with-dual-immunotherapy-for-first-line-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-gallium-68-labeled-fapi-pet-imaging-in-oncology-results-of-a-study-in-310-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/high-throughput-phenotypic-profiling-of-patient-derived-colon-cancer-organoids-to-reveal-a-chemoresi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-spatial-tumor-microenvironment-states-to-define-response-and-primary-resistance-to-immune-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-outcomes-in-first-line-1l-non-small-cell-lung-cancer-nsclc-with-maintenance-of-immune-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-immunotherapy-rechallenge-in-solid-tumors-after-discontinuation-of-immune-che 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-cell-multi-omics-and-tcr-sequencing-to-identify-early-tumor-cavity-homing-and-phenotypic-evol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transposon-engineered-hypoxia-inducible-t-cells-for-treatment-of-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preclinical-efficacy-and-brain-uptake-of-an-insulin-mediated-nanoparticle-co-delivering-trastuzumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leptomeningeal-carcinomatosis-in-pancreatic-cancer-clinical-presentation-management-and-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-immune-related-adverse-events-iraes-with-large-language-model-llm-embeddings 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-surgical-glove-compression-therapy-as-a-prevention-of-paclitaxel-induced-peripheral-neur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-results-from-a-phase-ii-study-of-tislelizumab-combined-with-radiotherapy-as-bladder-preserving 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-preliminary-efficacy-of-m9466-hrs-1167-in-combination-with-abiraterone-acetate-and-pred 2026-08-24 monthly 0.7 https://rjrindex.com/articles/peptide-receptor-radionuclide-therapy-with-sup177sup-lu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-chemotherapy-withwithout-pd-1i-in-locally-advanced-laryngealhypopharyngeal-cancer-a-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-exploratory-study-to-assess-the-safety-immunogenicity-and-preliminary-anti-tumor-activity-of-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/screening-for-intrinsic-and-acquired-resistance-mutations-to-anti-egfr-in-real-world-mss-colorectal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-seer-based-joinpoint-analysis-investigating-the-effect-of-shared-decision-making-on-prostate-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilisation-of-the-henry-score-in-malignant-bowel-obstruction-and-characterisation-of-management-app 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mitochondrial-dna-mtdna-expression-as-used-to-define-metabolic-and-immune-states-in-colorectal-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anitocabtagene-autoleucel-anito-cel-clinical-trial-manufacturing-experience-in-patients-with-relap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-endometrial-cancer-ec-survival-after-molecular-classification-mc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-talquetamab-vs-teclistamab-in-relapsed-refractory-multiple-myeloma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/grace-a-conversational-ai-platform-for-geriatric-oncology-risk-and-capability-evaluation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cxcl9spp1-ratio-macrophage-polarization-and-outcomes-with-pembrolizumab-or-enfortumab-vedotin-plus 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-depth-of-response-on-long-term-clinical-outcomes-exploratory-analyses-from-multiple-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-optimized-machine-learning-model-for-overall-survival-prediction-in-brain-metastasis-patients-usi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-prospective-trial-evaluating-duration-of-pd-1-and-pd-l1-inhibitor-therapy-in-advanced-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-abemaciclib-in-pn2-3-patients-with-hrher2-early-breast-cancer-real-world-outcomes-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-adoption-and-pathological-insights-of-neoadjuvant-chemoimmunotherapy-in-resectable-nsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-validation-of-a-brain-cancer-liquid-biopsy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clonal-hematopoiesis-in-head-and-neck-carcinomas-receiving-immunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/redefining-lung-cancer-screening-eligibility-smoking-duration-vs-pack-years-in-a-national-va-cohor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-single-institution-retrospective-analysis-of-the-distinct-differences-between-spontaneous-malignan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hi-c-sequencing-to-identify-clinically-actionable-fusions-in-non-small-cell-lung-cancer-missed-by-ot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ib-results-from-the-phase-ibii-study-of-sup177sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hippocampus-avoidance-versus-standard-prophylactic-cranial-irradiation-for-small-cell-lung-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ultrasensitive-ctdna-detection-for-relapse-and-response-prediction-in-melanoma-patients-treated-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-burden-among-adults-with-type-2-diabetes-mellitus-in-the-united-states-1999-2023 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-oncology-board-exam-readiness-through-a-longitudinal-review-curriculum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-circulating-small-extracellular-vesicle-mirnas-for-immunochemotherapy-response-in-es-sclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ptprz1-met-fusion-and-induction-of-reprogrammed-immuno-microenvironment-via-met-ifn-v-lgals9-signali 2026-08-24 monthly 0.7 https://rjrindex.com/articles/virtual-ai-informed-immunocyte-profiling-vaip-from-hampe-as-a-predictor-of-multi-cancer-prognosi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-study-of-bl-m05d1-a-novel-claudin182-directed-antibody-drug-conjugate-adc-in-patients-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breaking-the-stromal-barrier-in-bladder-tumor-with-a-urea-powered-platelet-nanomotor-for-potentiated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-hematological-parameters-and-timing-of-immunotherapy-administration-on-outcomes-in-first-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/opportunistic-plasma-ctdnatesting-in-egfr-mutant-mnsclc-using-a-hospital-validated-sequencing-platfo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-immune-checkpoint-inhibitor-related-pneumonitis-in-non-small-cell-lung-cancer-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-antibody-drug-conjugate-target-antigen-expression-in-patients-with-biliary-tract 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-of-stk11-keap1-and-nfe2l2-mutations-in-lung-squamous-cell-carcinoma-treat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-cooking-related-household-air-pollution-hap-on-never-smoker-nsclc-risk-in-women-systema 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-analysis-examining-liquid-biopsies-with-tissue-biopsies-in-patients-with-advanced-no 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-real-world-outcomes-with-talquetamab-and-teclistamab-in-relapsedrefractory-multiple-mye 2026-08-24 monthly 0.7 https://rjrindex.com/articles/central-nervous-system-metastases-in-gynecologic-cancers-real-world-outcomes-and-prognostic-factors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/once-unthinkable-population-level-changes-in-five-year-survival-for-metastatic-non-small-cell-lung 2026-08-24 monthly 0.7 https://rjrindex.com/articles/taxane-and-platinum-combination-as-a-predictor-of-pathologic-complete-response-in-i-spy2-by-gene-exp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/novel-transposon-baff-car-t-cells-lmy-920-for-non-hodgkin-lymphoma-nhl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-larotrectinib-in-patients-with-itrki 2026-08-24 monthly 0.7 https://rjrindex.com/articles/developing-workshops-to-enhance-self-efficacy-among-patients-in-cancer-survivorship-a-collaborative 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-framework-for-monoclonal-b-cell-lymphocytosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-clinical-outcomes-for-patients-with-deficient-mismatch-repair-dmm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/explainable-ai-to-enable-precision-risk-stratification-for-advanced-melanoma-in-underrepresented-mid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-impact-of-comprehensive-genomic-profiling-in-colon-cancer-evidence-from-community-oncolo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-vistatim3-heterodimerization-and-macrophage-metabolic-reprogramming-in-microsatellite-stabl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-trends-in-early-onset-uterine-cancer-and-the-rising-bmi-attributable-burden-a-population-bas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ponv-risk-score-and-gender-as-predictors-of-delayed-ambulation-in-outpatient-thyroid-and-parathyroid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stable-colorectal-cancer-burden-in-inflammatory-bowel-disease-over-a-decade-nationwide-us-trend-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/designing-a-triple-negative-breast-cancer-patient-journey-a-multi-stakeholder-initiative-to-improve 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-survival-and-treatment-compliance-of-cancer-patients-enrolled-in-medication-access-progra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/doacs-versus-vitamin-k-antagonists-for-cancer-associated-vte-updated-systematic-review-and-meta-ana 2026-08-24 monthly 0.7 https://rjrindex.com/articles/iparomlimab-and-tuvonralimab-pd-1ctla-4-bifunctional-antibody-monotherapy-or-combination-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/geographic-and-demographic-differences-in-genomic-testing-and-outcomes-in-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-adjuvant-treatment-strategies-in-locally-advanced-gastroesophageal-and-gastric 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-associated-bradyarrhythmias-and-inpatient-deterioration-in-us-hospitalizations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-immunotherapy-on-sotorasib-toxicity-in-nsclc-a-real-world-matched-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/brca-p-can-denosumab-reduce-breast-cancer-risk-in-ibrca1i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pre-diagnostic-imaging-and-radiology-report-based-risk-modeling-for-pancreatic-ductal-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/her2-discordance-in-upper-gastrointestinal-cancers-in-a-us-based-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cider-secure-high-throughput-extraction-of-clinical-variables-from-non-english-pathology-reports-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/histopathological-patterns-of-breast-cancer-at-diagnosis-among-patients-in-the-federal-capital-terri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-trends-in-leukemia-incidence-by-age-sex-and-sociodemographic-index-a-gbd-2023-joinpoint-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridges-a-phase-3-randomized-trial-of-immediate-postoperative-cesium-131-tile-based-radiation-thera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/induction-adebrelimab-combined-with-chemotherapy-followed-by-response-adaptive-concurrent-chemoradio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-trial-to-evaluate-csf-ctdna-and-safety-of-plixorafenib-alone-or-with-retifanlimab-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-the-rates-of-hypersensitivity-reactions-in-patients-undergoing-first-dose-taxanes-utilizin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/venous-thromboembolism-as-a-trigger-for-acute-cardiac-decompensation-during-cancer-hospitalizations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-reliability-of-isatuximab-subcutaneous-on-body-injector-results-across-the-phase-3-irakl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-real-world-study-on-the-efficacy-and-safety-of-anlotinib-in-combination-with-immunot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validating-a-single-item-screener-for-low-digital-health-literacy-among-surgical-oncology-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-based-decision-support-for-icu-admission-in-febrile-oncology-patients-optimizing-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distinct-multi-omic-signatures-that-underlie-ikrasi-var 2026-08-24 monthly 0.7 https://rjrindex.com/articles/icbfbi-mutations-as-a-predictive-biomarker-of-endocrine-therapy-benefit-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-prognostic-impact-of-recurrence-in-esophageal-carcinoma-patients-achieving-complete-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/proteomic-profiling-of-circulating-tumor-cells-ctcs-in-metastatic-urothelial-cancer-muc-as-assoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-implementation-of-an-online-family-cascade-genetic-testing-platform-the-preventive-risk-ou 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-utilization-of-bispecific-t-cell-engager-therapy-for-relapsedrefractory-multi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oxybutynin-for-vasomotor-symptoms-across-cancer-related-and-menopause-associated-settings-a-systema 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-short-term-fasting-compared-to-free-diet-in-ovarian-cancer-patients-results-from-a-two-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/precision-risk-stratification-for-lung-cancer-in-copd-evidence-from-the-all-of-us-program 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiovascular-disease-incidence-in-women-with-early-onset-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-characteristics-of-clinical-trials-presented-in-asco-plenary-sessions-2011-2025 2026-08-24 monthly 0.7 https://rjrindex.com/articles/knowledge-distillation-enabled-resnet-framework-for-hepatocellular-carcinoma-diagnosis-on-multiphase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-post-traumatic-stress-disorder-and-associated-factors-among-adult-sarcoma-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-plenary-to-practice-a-large-language-model-llm-based-thematic-analysis-of-landmark-clinical 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-naive-multimodal-cfdna-mrd-assay-to-predict-recurrence-in-a-prospective-cohort-of-patients-und 2026-08-24 monthly 0.7 https://rjrindex.com/articles/therapy-related-myeloid-neoplasms-after-radioligand-therapy-in-neuroendocrine-tumors-a-multicenter 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-trial-of-single-dose-neoadjuvant-pd-1-blockade-with-or-without-a-cd40-agonist-in-hpv-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-effectiveness-of-adjuvant-chemotherapy-on-survival-in-node-positive-n2n3-stage-iii-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-human-immunodeficiency-virus-on-in-hospital-outcomes-among-patients-hospitalized-with-mult 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-serpentine-trial-a-phase-ii-clinical-study-decoding-immune-responses-by-scrna-seq-and-tcr-seq-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differential-risk-patterns-of-secondary-breast-cancer-in-medullary-versus-papillary-thyroid-carcinom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-stromal-fak-signaling-to-address-chemotherapy-and-immunotherapy-resistance-in-gastric-type 2026-08-24 monthly 0.7 https://rjrindex.com/articles/zanubrutinib-plus-rituximab-as-front-line-treatment-for-mucosa-associated-lymphoid-tissue-malt-lym 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-real-world-overall-survival-between-atezolizumab-and-durvalumab-containing-first-line 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quality-adjusted-survival-comparison-for-tislelizumab-tis-chemotherapy-ct-versus-placebo-pbo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/jskn016-a-first-in-class-anti-trop2her3-bispecific-antibody-drug-conjugate-adc-in-patients-pts 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-feasibility-of-cabozantinib-cabo-in-combination-with-cisplatin-doxorubicin-and-high-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-ctdna-tumor-fraction-tf-dynamics-to-refine-progression-free-survival-and-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/propensity-score-matched-analysis-of-trifluridine-tipiracil-plus-bevacizumab-ftdtpibev-vs-anti-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-fertility-concerns-on-endocrine-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/camrelizumab-combined-with-liposomal-doxorubicin-and-dacarbazine-as-first-line-therapy-for-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-immune-programs-and-association-with-toxicity-burden-and-antitumor-response-during-immu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-versus-adjuvant-chemotherapy-for-resectable-high-grade-soft-tissue-sarcoma-a-real-world 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hrs-4642-combined-with-adebrelimab-in-previously-treated-patients-with-metastatic-pancreatic-ductal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/subgroup-analyses-by-disease-volume-and-ide-novoi-recu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-effect-of-glucagon-like-peptide-1-glp-1-receptor-agonists-on-outcomes-in-metastatic-non-small 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-remote-emotional-support-and-symptom-self-management-intervention-remi-a-pilot-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparative-effectiveness-of-decitabinecedazuridine-plus-venetoclax-versus-azacitidine-p 2026-08-24 monthly 0.7